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Background 
CRC risk can be reduced though lifestyle modification and regular screenings. Providing 
CRC risk feedback that promotes preventive behaviors to those at average risk has the potential 
to significantly reduce CRC morbidity and mortality.  
Purpose 
The purpose of this dissertation was to examine the impact of CRC risk assessment feedback 
among adults aged 50-75 with no personal or family history of the disease. The specific aims 
were to: (1a) test personalized (vs. generic) risk assessment feedback on individuals’ risk 
perceptions and intentions to engage in three risk-reducing behaviors (e.g., physical activity, diet, 
and screening); (1b) determine if the provision of CRC risk information influences breast cancer 
risk perceptions and mammography intentions; (2a) examine individuals’ accuracy of perceived 
lifetime risk of CRC; (2b) assess whether improved accuracy following risk assessment was 
associated with changes in behavioral intentions; and finally, (3) evaluate the use of a unique 
sampling procedure designed to increase diversity of survey respondents. 
ix 
 
 
Methods 
A pre-post parallel, two arm randomized controlled trial examined the effects of providing 
CRC risk assessment feedback that included lifetime risk estimates and information about CRC 
risk factors that was either personalized (treatment) or generic (control). N=419 average risk 
adults between the ages of 50-75 were recruited from a commercial online panel.  
Results 
There were no differences in risk perception between study arms. Overall participants, 
perceived lifetime risk of CRC lowered at post-test and seemingly produced a spillover effect in 
lowered perceived lifetime risk of breast cancer among females. CRC screening intentions 
increased in both study arms and mammography intentions increased in the control arm. 
Accuracy of lifetime risk improved at post-test, but was not associated with changes in intentions 
to perform risk reducing behaviors. Quota sampling acquired a targeted and diverse sample 
quickly and efficiently. 
Conclusion 
Communicating CRC risk information to average risk adults can improve CRC risk 
perception accuracy and enhance colorectal and mammography screening intentions. Risk 
assessment feedback did not consistently influence intentions to improve diet and physical 
activity.  
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CHAPTER 1 
INTRODUCTION 
Background 
Colorectal Cancer 
Colorectal cancer (CRC) is the third most common cancer diagnosed in both men and 
women and second leading cause of cancer deaths overall in the United States (US) [1]. Over 
130,000 people will be diagnosed with CRC and approximately 50,000 will die from the disease 
this year [2]. The chance that a man will develop CRC during his lifetime is 4.7%. The average 
lifetime risk for men of dying from CRC is 2.0% [3]. In other words, men have a 1 in 21 chance 
of being diagnosed with the disease and a 1 in 50 chance of dying from it. The average lifetime 
risks are comparable for women, albeit slightly lower (4.4% and 1.8% of developing and dying 
from CRC, respectively). These estimates represent average risks for men and women within the 
overall U.S. population; a given individual’s actual risk of developing CRC, however, may vary 
widely depending on their personal risk factors. 
Any attribute, characteristic, or exposure of an individual that increases the likelihood of 
developing a disease is known as a risk factor [4]. Risk factors are classified as either modifiable 
or non-modifiable. Non-modifiable risk factors for CRC include demographic characteristics 
such as age, race, and medical history. For example, the risk of CRC increases with age. 
Compared to younger aged individuals, the likelihood of developing CRC increases markedly 
among people aged 45-54 years and older, and is most frequently diagnosed among those aged 
65-74 years [1]. CRC is more prevalent among men than women and among African Americans 
[5]. CRC risk is also greater among those with a personal medical history of adenomatous polyps 
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(adenomas) or an inflammatory bowel disease (IBD), including ulcerative colitis or Crohn’s 
disease [6]. A familial history of CRC, adenomatous polyps, or other inherited (genetic) 
syndromes are also risk factors [7]. Although an individual cannot alter their risk based on 
demographic characteristics, other known factors associated with CRC risk are modifiable. 
Epidemiological studies have identified many modifiable factors that influence CRC risk, 
including lifestyle-related and behavioral characteristics. Specifically, physical inactivity, being 
overweight or obese, smoking, heavy drinking, and/or certain diets (e.g., high consumption of 
red and/or processed meats) are associated with an increased risk of CRC [5, 7, 8]. Factors 
associated with a reduced risk of CRC include a healthy diet including an adequate intake of 
dietary fiber and folate, fruit, vegetables, and/or dairy products, as well as certain medications 
(e.g., aspirin and hormonal treatments) [5]. 
Colorectal Cancer Risk-Reducing Behaviors 
Changes in health behavior can substantially reduce CRC incidence and the associated 
disease morbidity and mortality. The previously described lifestyle and behavioral risk factors 
can become risk-reducing factors if modified appropriately. For example, steps to reduce the risk 
of CRC include the following: maintaining a healthy weight; being physically active; consuming 
a healthy diet; limiting alcohol consumption; and avoiding tobacco products [5]. In addition to 
the management of risk factors, CRC screening is an important risk-reducing behavior. 
Screening can prevent disease development through the detection and removal of precancerous 
lesions [9]. Accordingly, U.S. evidence-based guidelines recommend routine screening for all 
adults age 50-75 years old [10].1 The association between modifiable factors and disease risk is 
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strong; in fact, as much as 70% of CRC cases could be prevented through lifestyle modification 
and widespread screening [11]. 
Despite the potential health benefits, most Americans do not engage in a healthy lifestyle. 
Behavioral risk factors associated with cancer are prevalent in the U.S. general population [12]. 
For example, almost 80% of American adults do not meet guidelines for physical activity [13]. 
Sedentary lifestyles combined with an unhealthy diet have led to a dramatic increase in the 
prevalence of obesity and overweight in the US. As of 2010, two out of three American adults 
are either overweight or obese [14]. In addition, national CRC screening rates are also 
suboptimal; over a third of the age-eligible population remain unscreened [15]. The identification 
and communication of an individual’s modifiable risk factors may be an imperative first step in 
promoting risk-reducing behaviors. However, increased knowledge is not sufficient for 
behavioral change [16]; improved strategies to promote CRC screening and healthy lifestyles are 
needed. Specifically, how best to leverage risk factor information to engage people in cancer 
risk-reducing behaviors remains unknown. 
Risk and Risk Presentation 
Risk is a concept based on probability; disease risk is the chance that a disease will occur 
[11]. The term also that implies one possible outcome is negative and that there is some degree 
of uncertainty as to what the outcome will be [17]. Risk is often expressed in absolute or relative 
terms. Absolute risk is the chance of disease occurrence over a specific period of time (e.g., 5-
year, lifetime, etc.), while relative risk (also known as comparative risk), refers to an individual’s 
risk compared to a reference group (e.g., peers). Absolute and relative risks have traditionally 
been expressed either numerically (e.g., a 0% to 100% chance) or verbally (e.g., low risk). 
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Although both absolute and relative risk estimates can be presented in numbers, the resulting 
representations of risk are quite different. For example, a small increase in the average lifetime 
risk for CRC (e.g., 4% to 6%) appears much larger when presented using relative risk (e.g., 50% 
increased risk). For this reason, researchers recommend using absolute risk instead of relative 
risk to improve the understanding of quantitative risk information [18]. Nonetheless, presenting 
relative risk may be critical when the goal is to heighten risk perception, which is often the case 
in behavioral health interventions.   
The interpretation of risk information is further complicated by individual factors related to 
education, health literacy, and numeracy [19]. In fact, approximately two thirds of Americans 
aged 16 to 65 years do not have the level of numeric proficiency necessary to understand 
proportions expressed in verbal or numerical form or to interpret basic statistics [20]. In order to 
facilitate the interpretation of risk information, quantitative risk estimates are sometimes 
collapsed into categories and expressed in words instead (e.g., average vs. elevated risk). 
However, this broad representation of risk is less precise than numeric estimates and issues with 
interpretation persist since verbal expressions of risk such as “likely” or “elevated” can be 
interpreted in a variety of ways. Recent research has suggested that the presentation of risk in 
visual formats (e.g., pictographs, pie charts, and stick figures) aids in the comprehension and 
recall of risk information [21-23]. However, little is known about the effectiveness of using 
visuals to communicate risk of low probability events [21].      
 In summary, there is no “one-size-fits-all” best practice for the dissemination of risk 
information. A personalized approach to risk communication may be best for comprehension 
accuracy, but identifying the right presentation format for a given individual can be challenging 
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[17, 24]. Therefore, strategies to communicate risk effectively include presenting risk 
information in multiple formats (e.g., texts, tables, and graphics) [18]. 
Risk Perception, Behavior Change Intentions, and Behavior 
Risk perception refers to an individual’s beliefs about the likelihood of an occurrence of a 
particular health threat or the likelihood of developing a health problem [25]. Previous research 
has identified numerous influences that shape risk perceptions, including demographic (e.g., age 
[26] and race/ethnicity [27-28]), health [26-27], cognitive (e.g., numeracy), and 
psychological/affective (e.g., optimistic bias and cancer worry [26]) factors. Although a myriad 
of other factors influencing risk perception have been identified in the literature, research 
findings are not always consistent. For example, minorities report lower perceptions of cancer 
risk than Whites in some studies [28-29], while others study have found significant variation in 
risk perceptions by race/ethnicity [30-31]. The interplay between factors is also important. For 
example, minorities and older adults tend to have lower numeracy, and numeracy, in turn, can 
impact one’s ability to comprehend risk information [32]. The examination of these complex 
relationships, differences in research methodologies, such as the type of risk variable evaluated 
(e.g., absolute vs. relative), composition of study populations, and range of predictors assessed, 
make it difficult to draw conclusions across studies. Despite these differences, one factor is 
consistently identified in the literature; family history.  
Perceptions of disease risk, including CRC risk, are heavily influenced by a family history 
of the disease [26, 27, 33]. Recent research has even suggested that a family history of cancer 
may lead to “spillover” effects of altering the perception of risk for other types of cancer [34]. 
However, the majority of new CRC cases will develop among “average risk” individuals, those 
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with no known family history or other predisposing conditions (e.g., familial adenomatous 
polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC), among others) [35]. 
Focusing CRC prevention strategies on average risk individuals could impact incidence and also 
potentially benefit the significant portion of individuals who are unaware of their increased risk 
status due to having limited or incorrect knowledge of their family health history [36]. Therefore, 
research examining the factors that influence risk perception among an average risk population is 
warranted but has received relatively little attention in the literature.  
Risk perception and related constructs (e.g., perceived vulnerability, susceptibility, and 
probability) have been prominent components of behavioral health theories for decades [25]. 
Widely known theories emphasizing the role of risk perception in influencing behavior include 
the Health Belief Model [37], the Protection Motivation Theory [38] and the Precaution 
Adoption Process Model [39-40]. Other more complex theories have been developed to predict 
response to health risk information specifically, Marteau and Weinman’s adaptation of the 
Common Sense Model (CSM) of Illness Representation [41]. According to this model, health 
risk information is processed through an individual’s cognitive and emotional schemas. These 
representations of the health threat then influence the development of coping responses (e.g., 
behavioral change) to reduce the perceived threat. Within most individual-level theories of health 
behavior change, risk perception serves as a precursor of health-protective behavior change. 
Specifically, increased perception of risk serves as a catalyst to increase the likelihood of the 
performance of behaviors to reduce risk. From this perspective, behavioral change intentions are 
a prerequisite for behavior change. Although discrepancies between intention and behavior can 
occur [42], cancer screening intentions and attending screening are often correlated [43]. The 
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present study will focus on behavioral intentions, as assessment of behavior change is outside the 
scope this study. 
The perceived risk of CRC is low among the U.S. adult population [26, 44-45]. For 
example, 62% of the 2003 Health Information National Trends Survey (HINTS) respondents 
aged 45 and older with no personal history of CRC indicated their CRC risk was somewhat or 
very low, while far less endorsed being at moderate (30%) or somewhat high/very high risk (8%) 
[26]. Based on these empirical findings and the aforementioned theoretical conceptualizations 
(e.g., the Health Belief Model, etc.) of risk perception, behavioral interventions often focus on 
increasing individuals’ perceptions of risk. The purported positive association between perceived 
risk and risk-reducing behavior is generally supported, albeit often with relatively small effect 
sizes [46-48]. A recent meta-analysis of experimental studies, however, found that heightening 
risk appraisals (a composite variable comprised largely of perceived risk) had a medium effect 
on behavioral outcomes overall (d+ = 0.31 (k = 217), with larger effect sizes observed for dietary 
behaviors (d+ = 0.46 (k = 11) and exercise (d+ = 0.38 (k = 8) [49] – both modifiable lifestyle 
characteristics and key factors in cancer prevention [50]. In contrast, at least one study using 
cross-sectional, nationally representative data found no associations between perceived cancer 
risk and diet and exercise behaviors [51]. 
Among research on CRC screening behavior specifically, risk perception generally seems to 
encourage preventive behaviors as predicted by theories of health behavior. For example, a 
seminal review by Vernon and a more recent analysis of cross-sectional, nationally 
representative data, provide evidence that individuals who report greater perceived risk of CRC 
are more likely to screen than those who report lower CRC perceived risk [52-53]. Similarly, a 
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recent systematic review and meta-analysis of 58 studies by Atkinson and colleagues observed a 
small, positive, and statistically significant relationship between CRC risk perception and 
screening use [54]. 
In addition to examining CRC behavioral intentions following the provision of risk 
estimates for colorectal cancer, the proposed study will assess change in women’s breast cancer 
risk perceptions and mammography screening intentions. Previous research has identified 
“spillover” effects where a family history of one cancer was associated with altered risk 
perception for another [34]. However, it is not known whether cancer-specific risk results could 
produce similar effects on the perceptions of risk and screening intentions for other cancer types 
that share similar lifestyle based modifiable risk factors. This information could have important 
implications for cancer risk assessments. 
In conclusion, the equivocal findings related to CRC risk perception and behaviors overall 
may be due, in part, to a variety of factors such as disparate measures of perceived risk and 
issues related to risk perception accuracy. There is no “gold standard” instrument for assessing 
risk perception [55]. Although a new, multidimensional measure of risk perception was 
published in 2016 [56], the most commonly used measures consist of relatively few, face-valid 
questions, such as the HINTS survey items. In fact, the majority of the 58 studies reviewed in a 
recent meta-analysis of the literature examining risk perception and CRC screening measured 
CRC risk perception using a single item (64%) [54]. Moreover, type of risk used in the research 
reviewed was most often expressed verbally in relative (36%) or absolute (36%) terms, with far 
fewer studies employing numeric absolute or a combination of risk types (7 and 21%, 
respectively). Some experts assert that there are likely at least two dual processes at play in the 
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comprehension of risk information (e.g., cognitive/analytical/deliberative vs. 
affective/experiential/intuitive) [27, 57-59]. However, it has been noted that the affective system 
is likely to be more relevant among individuals with either a family history or symptoms of 
disease, compared to average risk groups [27]. Different measurements could also be the source 
of biased judgments about risk perceptions. For example, laypeople have been shown to 
overestimate their risk when assessing their CRC risk using numeric scales [60]; thus, categorical 
response options may be preferable. Alternatively, inaccurate risk perceptions present in research 
samples may be a reflection of the underlying difficulties laypeople have in the comprehension 
of numeric risk information related to numeracy. Providing cancer risk information may help 
correct risk perception inaccuracies and subsequently, drive intentions for preventive health 
behaviors more uniformly. 
Cancer Risk Assessment Tools  
As our understanding of cancer etiology and risk factors has advanced, growing numbers of 
risk estimation/prediction models and assessment tools, hereafter referred to jointly as risk 
assessment tools (RATs), have been developed to predict the occurrence of cancer and guide 
approaches to disease prevention [61]. RATs calculate an individual’s cumulative risk from 
multiple sources, including individual characteristics and behaviors, family history, and 
population-based estimates. A well-known use of RATs is to help clinicians identify individuals 
who are at high risk of cancer and thus enable risk-stratified recommendations for screening and 
disease prevention.  
Three recent reviews have been published summarizing the extant CRC RATs [50, 62-64]. 
Although specific model evaluations are beyond the scope of this study, the discriminatory 
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power of CRC RATs in general is regarded as comparable to other cancer risk models. There is 
heterogeneity among RATs in the array of risk factors included, sources of data used in model 
development (e.g., cohort vs. case-control studies), and outcomes predicted (e.g., subtypes of 
CRC). Moreover, most have not been validated in diverse populations. There is no single best 
RAT; each has unique strengths and limitations and provides varying risk types (e.g., absolute or 
relative) and presentation formats (e.g., with or without visuals). A content analysis of available 
internet-based cancer RATs was conducted in 2009 [65]. Among the 47 RATs identified, 10 
(21%) provided colorectal cancer risk information. Among all websites providing assessments, 
very few used risk communication formats that facilitate comprehension and reduce bias. For 
example, while the majority of sites were intended for lay audiences (89%), 83% contained 
undefined terminology (e.g., biopsy); and only five websites used both words and numbers to 
communicate risk. However, approximately one-third of sites provided at least one visual 
display, and one-half provided duration of risk (e.g., 5-year risk). This study suggests that online 
RATs have room to improve in conveying health risks. Despite these shortcomings, cancer 
RATs are becoming increasingly available to the public via online sources.  
Online Colorectal Cancer Risk Assessment Tools 
Among the several CRC RATs available online [66-70], perhaps the two most well-known 
are those developed by the Harvard Center for Cancer Prevention [70] and the tool made 
publically available by the NCI [67]. Both are easily accessible and frequently used in clinical 
and research settings. The tool that began as the Harvard Cancer Risk Index (HCRI), now 
available on the Your Disease Risk site [70], was one of the first calculators developed to predict 
individual cancer risk [71]. The current, easy-to-use online Your Disease Risk RAT predicts 
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relative risk; providing results in both verbal categories (e.g., below average) and a graphic 
representation. The HCRI also provides feedback on the risk-reducing behaviors respondents are 
already doing and specifies behaviors they could do to lower their risk. HCRI results, however, 
do not provide numeric risk estimates, which is a recommended format for communicating risk 
[18]. The NCI’s Colorectal Cancer Risk Assessment Tool (CCRAT) [67] was developed by 
Freedman and colleagues [72-73]. Results of this internet-based tool provide multiple numeric 
risk estimates and in addition, an invariant, bulleted summary of factors that can increase and 
lower CRC risk. The factors appearing on the list are not based on assessment responses and 
thus, may not apply to every respondent. For example, obesity is listed as risk factor, regardless 
of whether the respondent is normal weight, overweight, or obese.  
Although RATs are widely used in clinical practice, little is known about how risk feedback 
affects average risk individuals and those who access these tools online. Since the perceived risk 
of CRC is low in the general population [26, 44-45], RAT results that afford even average risk 
estimates could conceivably help individuals gauge their risk more accurately and motivate 
preventive health behaviors. However, little is known about the application of cancer risk 
prediction models for population approaches to cancer prevention or the use and utility of online 
cancer RATs among laypeople. A 2004 NCI-sponsored workshop on cancer risk prediction 
models highlighted their potential utility to facilitate both high risk and population level 
approaches to cancer prevention [61]. Workshop participants specifically expressed that since 
most cancers occur among individuals with approximately average individual risk, strategies for 
reducing lifestyle risk factor prevalence in the general population would yield maximum 
benefits. They also called for future research on how to effectively communicate risk to the 
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general public outside of the doctor-patient encounter. Additional research is needed to 
determine if the provision of RAT results will similarly alter risk perception among average risk 
individuals (e.g., excluding those with a family history of CRC in additional to those with a 
personal history) and whether RAT results influence cancer control-related behavioral intentions, 
including diet, physical activity, and screening. 
To my knowledge, only one study has examined the impact of CCRAT risk information on 
interest in CRC screening among lay individuals [74]. This study by Han and colleagues 
included a convenience sample of adults aged 51 years and older from the general public who 
accessed a website with a fully functional replica of the CCRAT. Although no main effects were 
found between CRC risk information and interest in screening, results revealed different interest 
in CRC screening subgroups, depending on prior screening history, estimated cancer risk, and 
baseline screening interest. CCRAT results provided in this study did not include the non-
quantitative, risk factor summary section. Therefore, it is unclear whether additional information 
on risk factors could impact interest in risk-reducing behavior. A 2006 Cochrane review 
concluded that personalized risk information mobilizes health behavior change [75]. Therefore, 
the utility of the CCRAT is potentially limited since the risk factor summary it provides is not 
personalized. 
The addition of personalized feedback on an individual’s risk factors and related lifestyle 
changes that would reduce their risk may help improve awareness related to cancer prevention 
within the general population, including the roughly 32 million Americans who believe nothing 
can reduce an individual’s cancer risk [76]. In addition to increasing awareness about risk 
factors, the utility of the CCRAT may be enhanced as the use of individually-tailored behavior 
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change information during a health risk assessment has previously been shown to promote health 
behaviors [77]. Risk assessment results providing both numeric risk estimates similar to the 
CCRAT and concrete, actionable behavior change recommendations corresponding to each risk 
factor, such as those provided by the Your Disease Risk tool, may produce more meaningful 
feedback. This may be especially true for average risk individuals, for whom no intensified 
preventive approaches apply. However, it is not known what, if any, beneficial changes in risk 
perceptions and intentions for behavioral change would result from this integrated format of risk 
factor feedback. The current study will explore this question and address this gap in knowledge 
needed to inform the future development and improvement of CRC RATs. 
Conceptual Framework 
The overarching conceptual framework guiding this study draws from the Common Sense 
Model (CSM) of self-regulation of health and illness [78]. This longstanding theoretical model 
has been used to understand the impact of risk information related to a health threat (instead of 
an illness) [79-80]. Consistent with other research [79], the cognitive processing components of 
the CSM (i.e., stimuli, representation of health threat, and coping) are conceptualized as risk 
information, risk perception, and behavioral intentions.  
As shown in Figure 1, the communication of risk information influences risk perceptions, 
which in turn, drive behavioral intentions to manage risk. Specifically, it is theorized that 
information about risk that is tailored to an individual’s actual risk factors and provides a 
personalized behavior change recommendation to reduce risk will heighten risk perceptions and 
subsequently, result in greater health behavior change intentions (compared to generic 
information) [81-82]. Knowledge and saliency of risk factors are depicted as influencing 
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(moderating) risk perception following the receipt of risk information, and attitudes (perceived 
consequences) and behavioral beliefs (perceived controllability) about cancer prevention are 
conceptualized as moderating factors between risk perception and behavioral intentions. In 
addition, numeracy and self-efficacy are included in the framework and will be controlled for in 
the final analyses.2 
Figure 1a. Overarching Conceptual Framework 
 
 
 
Within the treatment arm specifically, in which the risk factor summary is tailored to the 
individuals’ actual risk factors and provides a personalized behavior change recommendation to 
reduce cancer risk, the hypothesized pathways of causal mechanisms are shown in Figure 1b 
below in red arrows. First, the provision of personalized risk information is expected to increase 
knowledge about cancer prevention and saliency of risk factors significantly, compared to the 
generic feedback provided in control arm (a). Higher levels of risk factor knowledge and 
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saliency will subsequently enhance risk perceptions (b). Previous research supports the assertion 
that tailored messages are considered more relevant and result in greater health behavior change, 
compared to generic communication. In addition, increased knowledge on how to reduce risk 
will logically alter attitudes and beliefs about cancer prevention (perceived consequences and 
controllability) (c). Finally, more informed attitudes and beliefs about cancer prevention will 
then promote higher behavior change intentions when combined with already heightened risk 
perceptions (d). 
Figure 1b. Conceptual Framework: Treatment Arm 
 
 
 
Research Aims 
The primary focus of the present dissertation was to examine the impact of CRA feedback 
on CRC risk perceptions (primary outcome) and behavioral intentions (secondary outcome) 
among an average risk adult population. This research builds on previous risk communication 
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studies suggesting that personalized information about risk factors is more effective than generic, 
non-personalized information in enhancing risk perception accuracy [60, 83] and cancer 
screening utilization [75, 84]. The specific aims of the primary paper of this dissertation were as 
follows: 
 
Aim 1: Experimentally evaluate the effects of providing personalized (vs. generic) 
information on CRC risk factors on risk perceptions and behavioral intentions among an 
average risk adult population. 
Hypothesis 1: Risk perceptions will be higher among those who receive 
personalized information, compared to generic. 
Hypothesis 2: Behavior change intentions will be higher among those who receive 
personalized information, compared to generic. 
Aim 2: Explore whether the provision of CRC risk information alters breast cancer risk 
perceptions and mammography screening intentions among female participants. 
Hypothesis 3: Breast cancer risk perception will be higher among those who 
receive personalized information, compared to generic. 
Hypothesis 4: Mammography screening intentions will be higher among those 
who receive personalized information, compared to generic. 
 
The existing body of research on CRAs has shown improved risk perception accuracy 
following risk assessment feedback [60, 83, 85-86]. However, few studies have evaluated the 
impact of CRA feedback on average risk individuals (i.e., individuals with no known history of 
CRC). Advanced approaches to CRC prevention including strategies aimed at the entire at-risk 
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population may be particularly important given the high prevalence of modifiable risk factors in 
the general population and because intervening with the populace would yield more cumulative 
benefits than focusing on those at high risk alone. Since perceived risk of CRC is low [26, 44-45] 
and the actual risk of CRC of someone at average risk is relatively low, it is unclear if improving 
risk perception accuracy would be beneficial (e.g., promote risk reducing behaviors) or 
detrimental (i.e., foster a false sense of security that hinders the adoption of preventive 
behaviors). Thus, research is needed to assess factors associated with post-CRA lifetime risk 
perception accuracy and the behavioral implications of altering accuracy among average risk 
individuals. Accordingly, the second paper of this dissertation addressed this gap in knowledge 
through the following aims: 
 
Aim 1: Characterize perceived lifetime risk prior to CRA feedback. 
Aim 2: Examine predictors of baseline perceived lifetime risk accuracy. 
Aim 3: Identify predictors of improved risk perceptions among those who were 
inaccurate at baseline. 
Aim 4: Assess whether improvement in perceived lifetime risk accuracy was associated 
with changes in behavior change intentions for physical activity, diet and attending CRC 
screening. 
 
In addition to these research aims, this dissertation sought to characterize the validity of the 
online panel sample utilized in the present research. Understanding the strengths and potential 
pitfalls of using online panels is critical to making informed decisions about research strategies, 
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especially when targeting groups typically underrepresented in research samples, such as 
minorities and older adults. Thus, the specific aims of the final paper were to: 
 
Aim 1: Describe the recruitment and participant flow of a survey administered by a 
commercial research platform using quota sampling. 
Aim 2: Describe the sociodemographic characteristics of eligible respondents that 
complete the survey and respondents that initiate, but do not complete the survey. 
Aim 3: Compare sociodemographic profiles of survey completers to respondents that 
initiate, but do not complete the survey. 
Aim 4: Determine when study-eligible non-completers exit the survey. 
 
Results of this dissertation afforded valuable insights into the potential utility of CRAs to 
alter risk perceptions and drive risk-reducing behaviors. Findings provided insight regarding 
which participants benefited from improved accuracy after receiving CRA feedback and how 
behavioral intentions were impacted as a result of improved accuracy. The sampling methods 
used in this study were also examined. Such information is imperative to the improvement and 
development of the next generation of CRA tools, as well as to the design of interventions to 
improve cancer preventive behaviors. 
 
  
  
 
 
 
 19 
Footnotes 
1 CRC screening guidance referenced in this study was based on that provided by the U.S. 
Preventive Services Task Force, which remains the same at the time of this dissertation 
draft. However, it should be acknowledged that the American Cancer Society updated 
their guidelines in 2018, recommending that those at average risk of CRC should screen 
regularly between the ages of 45-75 years old – five years earlier [87]. 
2  Intervention arm (generic vs. personalized) was not a significant predictor of either risk 
perceptions or behavioral intentions in multivariate analyses controlling for the other 
variables in the model. There were also no significant differences in risk perception or 
other intermediate variables between intervention groups. Subsequently, the moderating 
relationships proposed in this model, illustrating a causal pathway, were not warranted. 
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CHAPTER 2 
Paper One 
THE EFFECTS OF PERSONALIZING COLORECTAL CANCER RISK COMMUNICATION 
ON RISK PERCEPTIONS AND HEALTH BEHAVIOR INTENTIONS: A RANDOMIZED 
TRIAL OF AVERAGE RISK ADULTS 
Abstract 
Background 
Risk assessment tools may help individuals gauge cancer risk and motivate lifestyle changes 
and other risk-reducing behaviors, such as routine cancer screenings. Despite the evermore 
common availability of such tools, little is known about the potential utility of risk assessment 
tools for population approaches to cancer prevention. 
Purpose 
We evaluated the effects of providing personalized (vs. generic) colorectal cancer (CRC) 
risk assessment feedback on average-risk individual’s risk perceptions and intentions to engage 
in three risk-reducing behaviors: CRC screening, diet, and physical activity. We also examined 
whether the provision of CRC risk assessment information alters breast cancer risk perceptions 
and mammography intentions. 
Methods 
We administered an accepted cancer risk assessment tool to an online panel sample. N=419 
survey respondents aged 50-75 with no personal or family history of CRC were randomized to 
receive lifetime CRC risk estimates and risk factor information that was either personalized 
(treatment) or invariant/non-personalized (control). Respondent cancer risk perceptions and 
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behavioral intentions were ascertained immediately before and after risk assessment 
administration.  
Results 
No differences were observed in risk perception or behavioral intentions between groups. 
However, CRC screening intentions and intentions to talk to a doctor about CRC screening 
significantly increased in both groups. In addition, within both groups, the average lifetime risk 
of colorectal and breast cancers reported significantly decreased. 
Conclusion 
Results support the potential role cancer risk assessment information could play in 
promoting cancer screening behaviors, while highlighting the known difficulty of using risk 
information alone to “moving the needle” on lifestyle modifications among individuals without a 
cancer history. Reductions in perceived lifetime risk of CRC seemed to spillover onto female 
participants’ perceived lifetime risk of breast cancer. How best to leverage benefits from (while 
minimizing negative impact of) the spillover effects from risk communication targeting one 
disease on other disease warrants additional consideration. 
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Background 
Colorectal cancer (CRC) is the third most common cancer and second leading cause of 
cancer death overall in the United States (US) [1]. Over 130,000 people will be diagnosed with 
CRC and approximately 50,000 will die from the disease this year [2]. The majority of new CRC 
cases will develop among “average risk” individuals, those with no known family history or 
other predisposing conditions (e.g., familial adenomatous polyposis (FAP) and hereditary non-
polyposis colorectal cancer (HNPCC)) [3]. The association between modifiable factors and CRC 
risk is strong; as much as 70% of CRC cases could be prevented through lifestyle modification 
and widespread screening [4]. Therefore, modifying behavioral risk factors within the average 
risk population could substantially reduce CRC incidence and associated morbidity and 
mortality. 
Lifestyle factors such as maintaining a healthy weight, being physically active, consuming a 
healthy diet, limiting alcohol consumption, and avoiding tobacco products can reduce the risk of 
CRC [5-6]. CRC screening is another important risk-reducing behavior as it can prevent disease 
development through the detection and removal of precancerous lesions [6-8]. Despite the 
potential health benefits, most Americans do not engage in CRC risk-reducing behaviors. 
Lifestyle risk factors associated with cancer are prevalent in the U.S. general population [9-10]. 
The identification and communication of an individual’s modifiable risk factors may help 
individuals gauge their CRC risk and motivate intentions to engage in lifestyle and other risk-
reducing behaviors, such as routine cancer screenings. Cancer risk assessment tools that convey 
this information are increasingly available to the public online [11]. Although evidence suggests 
online risk assessment tools are a promising approach for communicating risk and promoting 
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health behaviors in high risk individuals [12-14], little is known about the application of cancer 
risk assessments for population approaches to cancer prevention among those at average risk. 
Another unknown outcome of cancer risk assessments is what influence, if any, receiving 
risk information for a specific cancer type has on risk perceptions and behavioral intentions 
related to another cancer type. An earlier study by Rubinstein and colleagues identified “novel 
spillover effects” whereby having a family history of one cancer was associated with altered 
disease perceptions of another cancer type [15]. Therefore, it is conceivable that heightened 
perceived risk for one cancer (following receipt of risk assessment results for that cancer type) 
may alter an individual’s perceived risk and behavioral intentions related to another type of 
cancer (via spillover effects). Therefore, conceptually, a single intervention could be designed to 
improve multiple risk behaviors. This hypothesis has not been scientifically evaluated. 
While communicating risk may be an important step in shaping perceptions of disease risk, 
providing risk estimates alone may not be enough to drive health behaviors and behavior change 
intentions [16-22]. This may be especially true among individuals without a known family 
history who receive low or average numeric (e.g., <5%) or categorical (e.g., “unelevated”) risk 
estimates. When targeting individuals who do not have a known family history of cancer, it may 
be particularly important to increase information saliency by incorporating personalized 
information designed to heighten risk perception, and ultimately, drive behavioral change 
intentions.   
Personalized risk communication, including information tailored to individuals’ unique risk 
factors has been shown to increase accuracy of risk perceptions [23-24] and mobilize cancer 
screening utilization [25-26]. Another study similarly found improvements in breast cancer risk 
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perceptions and physical activity intentions within the personalized condition (compared to non-
personalized) [27]. To our knowledge, no study has compared the effects of providing CRC risk 
feedback with personalized feedback (compared to generic) regarding risk factors, in addition to 
personalized risk estimates (e.g., lifetime risk), on behavioral intentions as well as risk 
perceptions among average risk individuals.  
The primary objective of this study was to experimentally evaluate the effects of providing 
personalized (vs. generic) information on CRC risk factors on risk perceptions and behavioral 
intentions among an average risk adult population. In secondary analyses, we also explore 
whether the provision CRC risk information alters breast cancer risk perceptions and 
mammography screening intentions among female participants. Consistent with the evidence 
favoring personalized risk communication [28], the primary hypothesis of this study was that 
(H1) CRC risk perception will be higher among those receiving personalized information, 
compared to the control. Secondary hypotheses also assessed were that compared to controls, 
(H2) behavior change intentions regarding CRC screening, healthy diet, and physical activity 
will be higher among treatment participants; and among female participants, (H3) breast cancer 
risk perception and (H4) mammography screening intentions will be higher among treatment 
participants. 
Methods 
Study Design 
We used a pre-post parallel trial design to evaluate the effect of providing personalized risk 
factor information. An online survey was administered through Qualtrics, an internet-based 
survey and research company, in June 2017. Participants were randomized to receive either 
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personalized or generic information on risk factors. Randomization occurred after completing 
screener items and the pre-intervention survey but prior to the post-intervention survey and 
remaining demographic items (e.g., marital status, education attainment, and employment status). 
Randomization was carried out by Qualtrics using the Mersenne Twister algorithm, a commonly 
used and widely accepted form of random number generation [29-30].  
Participant responses to risk perception and behavioral intention questions were collected 
prior to and immediately following receipt of CRC-specific risk feedback. Prior to beginning the 
risk assessment tool, participants were queried for information necessary to determine sample 
eligibility (e.g., age, race, household income, state of residence, and personal and family cancer 
history), and asked to complete a brief series of questions measuring sociodemographic 
characteristics including gender, education attainment, marital status, employment status, and 
insurance status. Baseline (pre-intervention) behaviors were queried to ascertain cancer 
screening status and to detect the presence of lifestyle risk factors (physical activity and diet) 
using previously developed items [31-33]. All survey items required a response; therefore, there 
were no skipped or missing responses. Upon survey completion, participants could select from a 
variety of incentive options worth approximately $5.00. This study was approved by an 
Institutional Review Board (IRB) following expedited review. 
Sample and Survey Administration 
Qualtrics acquired the sample from existing pools of research panel participants.1 
Recruitment targeted potential survey respondents who were likely to qualify based on the 
demographic characteristics reported in their user profiles (i.e., race and age). Panelists were 
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invited to participate via email and opted in by activating a survey link that directed them to the 
study consent form. 
Quota sampling was used to obtain a sample that was diverse with respect to household 
income and race. A balanced sample of White, Black/African American, and 
Hispanic/Latino/Spanish participants was requested. Respondents identifying as some other race 
were not eligible to participate. Eligible panel participants included residents of the contiguous 
U.S. with the ability to read and comprehend English language. In addition, participants were 
screened for the following eligibility criteria: age 50-75 years old (age-eligible for CRC 
screening) and no personal or family history of CRC or other predisposing factor (i.e. 
inflammatory bowel disease, polyps or a hereditary syndrome such as familial adenomatous 
polyposis (FAP) or hereditary nonpolyposis colon cancer (HNPCC), also known as Lynch 
Syndrome). Individuals who reported an age outside the range of 50-75 years or any 
predisposing factor were excluded. In addition, respondents were removed from the survey if 
they responded incorrectly to any of the three “attention checks” (i.e., survey items that 
instructed respondents to provide a specific response). 
Risk Information 
All participants, regardless of study arm, received gender-specific, population-level lifetime 
risk of developing CRC in the United States (Figure 1) [34]. Risk factor information was 
presented immediately following the numeric risk estimates, according to study group. 
Participants randomized to the control group received a summary describing 11 factors that can 
increase and lower risk of CRC (Figure 2) [35-36]. Within the treatment group, the risk factor 
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information provided was tailored to each respondent’s actual risk profile (i.e., the 
presence/absence of risk factors as reported by each respondent). 
To test the influence of personalized risk factor information on risk perception and 
behavioral intentions, three modifiable CRC risk-reducing behaviors were chosen (screening, 
physical activity, and diet). The specific content of the individually tailored risk summary was 
adapted from the prevention messages provided by existing online risk assessment tools [35, 37-
38]. Each targeted behavior was framed as either a risk (Figure 3a) or protective (Figure 3b) 
factor based on participant reported engagement in that behavior. Any behaviors listed as a risk 
factor included a behavior change recommendation. Each risk factor message also included 
information about the consequences of the behavior (i.e., performing this behavior will reduce 
risk). The wording of these statements was developed based on Prospect Theory [39] and in 
accordance with prior research demonstrating that gain-framed messages tend to be more 
effective in promoting prevention behaviors and intentions, including diet [40] and physical 
activity [41], whereas loss-framed behaviors are more effective in promoting diagnostic 
behaviors and intentions (e.g., cancer screenings) [42-43]. Table 1 provides the protective and 
risk message content corresponding to each of the three behaviors. 
Outcome Measures 
Cancer Risk Perceptions. 
The primary outcome, CRC numeric lifetime risk, was assessed by asking, “On a scale from 
0 to 100 %, how would you rate the probability that you will develop colorectal cancer in the 
future?” with an open-response of 0-100%. “How likely is it that you will get colorectal cancer at 
some point in the future?” was used to assess absolute risk using a five-point Likert scale ranging 
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from “very unlikely” to “very likely.” Relative risk was also measured with the question, “How 
do you think your chance of developing colorectal cancer in the future compares to the average 
person of your gender and age?” with responses ranging from “much lower” to “much higher” 
on a five-point Likert scale. These three individual items were also adapted to assess perceived 
absolute, relative, and numeric lifetime risk of breast cancer among female participants.  
Dichotomous measures of accuracy were created for reported numeric lifetime risk of 
colorectal and breast cancers. Accurate lifetime risk of CRC was defined using statistics from the 
American Cancer Society [2], as a response between four and five percent. The average lifetime 
risk of women developing breast cancer is approximately 12% [44]; therefore, responses 
between 10-15% were coded as accurate. The wider range of reported breast cancer risk was 
considered accurate since no estimates were provided to respondents.  
Behavior Change Intentions. 
Behavior change intentions related to CRC screening, mammography screening, physical 
activity, and diet, as well as intentions to talk to a doctor about getting tested for CRC, were 
assessed at pre- and post-intervention. Based on previous CRC screening research [45], 
respondents were asked a single item adapted for each behavior, “How likely are you to [get 
screened for colorectal cancer, improve your diet, and increase your physical activity] in the next 
6 months?” on a five-point Likert scale “not at all to “extremely.” Participants classified as up-
to-date on CRC or mammography screening based on their prior responses about screening 
history, were asked about screening intentions with an alternative ending, “…when you are due 
to screen again?”  
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Analyses 
Independent samples t-tests were used to test differences between treatment and control 
groups in the primary outcome (i.e., post-intervention CRC numeric lifetime risk perception). 
Subsequent independent samples t-tests and chi-squared tests of association (for categorical 
outcomes) were used to test for differences between intervention groups in secondary outcomes 
(i.e., absolute and relative risk perceptions, behavioral intentions, and breast cancer risk 
perception at post-intervention). To explore within group differences a series of ad hoc analyses 
were performed using paired samples t-tests (for continuous outcomes) and McNemar's tests (for 
categorical outcomes) to detect changes within each group (from pre- to post-intervention). 
Results 
Sample 
Approximately 63,500 panelists were sent survey invitations. Among those solicited for 
participation, 1,448 panelists clicked on the survey link and consented to participate, including 
n=671 ineligible panelists per study criteria and an additional 220 per sample quota criteria (i.e., 
over quotas). Among the remaining 557 respondents, 71 failed to complete the survey (13%) and 
an additional 67 were removed for failing an attention check (i.e., they did not provide the 
requested response) (12%). A total of n=419 completed surveys were collected from study 
eligible participants, resulting in a 24% response rate [46]. Sample characteristics overall and by 
intervention arm are provided in Table 2. 
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Primary Outcome 
CRC Numeric Lifetime Risk Perception. 
 No significant differences were observed in any of the post-intervention CRC risk 
perception measures between the treatment and control groups (Table 3). However, within both 
groups, the average numeric lifetime risk reported was significantly reduced at post-test 
(compared to pre-test) (t(211) = -5.576, p < .001 and t(206) = -4.848, p < .001 for treatment and 
control, respectively) and indicated greater accuracy in lifetime risk (χ2(1) = 87.258, p < .001 and 
χ2(1) = 60.800, p < .001, for treatment and control, respectively). 
Secondary Outcomes  
CRC Absolute and Relative Risk Perceptions. 
The single item indicator of absolute risk of CRC was approaching statistical significance 
(t(417) = -1.874, p = .06), with higher risk reported in the treatment group, compared to control 
(Table 3). Post-hoc tests assessing pre-post change in each group found a significant increase in 
absolute risk was observed within the treatment group at post-test, compared to pre-test (t(211) = 
2.677, p = .008). Relative risk trended towards a significant decrease within the treatment group 
(t(211) = -1.818, p = .07). There were no significant differences in absolute or relative risk 
perception within the control group.  
Behavior Change Intentions. 
Post-test intentions to talk to a doctor about CRC screening and intentions for CRC 
screening, diet and physical activity did not differ significantly by study arm (Table 3). However, 
behavioral intentions increased for screening, diet, and physical activity among 25-30% of all 
participants (data not shown). In post-hoc analyses of pre-post change significant increases in 
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intentions to talk to a doctor about CRC screening (t(211) = 3.932, p < .001 and t(206) = 5.148, p 
< .001 for treatment and control, respectively) as well as CRC screening intentions (t(211) = 
3.961, p < .001 and t(206) = 4.783, p < .001 for treatment and control, respectively) were 
identified. Physical activity intentions increased within the control group only (t(206) = 2.175, p 
= .031), while diet intentions did not significantly change within either group. 
Breast Cancer Risk Perceptions. 
There were no significant differences observed in any of the post-intervention breast cancer 
risk perception measures between the treatment and control groups (Table 3). There were no 
significant differences within groups in absolute or relative perceptions of breast cancer risk, 
although a decrease in absolute risk at post-invention was approaching significance within the 
control group (t(137) = -1.914, p = .06). Within both the treatment and control groups, the 
average numeric lifetime risk of breast cancer reported was significantly lower at post-test 
compared to pre-test (t(140) = -2.142, p =.034 and t(137) = -3.111, p = .002, for treatment and 
control, respectively); accuracy in numeric lifetime risk of breast cancer, however, did not 
change significantly within either group. Post-hoc McNemar’s tests revealed that the overall 
proportion of individuals who overestimate their lifetime risk of breast cancer significantly 
decreased, while the overall proportion of individuals who underestimate significantly increased 
(χ2(1) = 7.902, p < .01 and χ2(1) = 6.919, p < .01, overestimate and underestimate, respectively) 
[data not shown]. 
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Mammography Screening Intentions.  
Post-test mammography screening intentions did not differ significantly by intervention arm. 
Intentions for mammography screening increased within the control group (t(137) = 2.166, p = 
.032). There were no significant changes within the treatment group. 
Discussion 
Although the hypothesized differences between study arms in post-intervention risk 
perceptions and behavioral intentions were not supported, several significant within group 
differences were observed. Specifically, perceived numeric lifetime risk of CRC lowered and 
seemed to spillover onto female participants’ perceived lifetime risk of breast cancer. Results 
also suggest that cancer risk assessment tools may facilitate behavior change intentions, 
especially screening intentions. Taken together, findings suggest that risk communication 
interventions may not need to provide personalized content to improve accuracy of perceived 
numeric lifetime risk and drive screening intentions among those at average risk of CRC. 
The null results between groups on risk perceptions and behavioral intentions do not 
necessarily contradict the body of literature favoring personalization over non-personalized risk 
communication [25, 47]. In this study, it is possible that the personalized component of the risk 
results was overshadowed by the lifetime risk estimate provided to participants. That the overall 
lifetime risk of participants decreased suggests that the numeric estimate may have been more 
salient than the information provided on risk factors (regardless of personalization). Therefore, 
future risk communication research targeting those at average should emphasize that average risk 
is not zero risk and make messages on the outcomes related to specific lifestyle changes, e.g., the 
number of CRC cases or CRC deaths that could be prevented, the central focus of the risk 
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feedback. In order to prevent diminished risk perception among those at average risk, risk 
communication strategies could also aim to increase awareness of the prevention paradox, the 
common scenario in which the majority of cases of a disease occur in those at low or moderate 
risk, while only a same percent occur in those at high risk [48].  
Numeric lifetime risk of CRC reported at post-intervention was significantly lower than at 
pre-intervention in both intervention arms. This reduction reflects greater accuracy in perceived 
lifetime risk and adds to the body of literature demonstrating improved risk perception accuracy 
after risk assessment feedback [23-24, 27, 38, 49]. Additional research is needed to identify the 
cognitive and behavioral implications of altering lifetime risk perception accuracy among 
average risk individuals. In particular, future studies should evaluate whether increased risk 
perception accuracy among average risk individuals is beneficial or detrimental (i.e., leads to a 
false sense of security and impedes adoption of health behaviors). 
Women’s’ perceived lifetime risk of breast cancer also significantly decreased at post-
intervention (compared to pre-intervention), regardless of study arm. These unexpected changes 
in women’s perceived lifetime risk of breast cancer following CRC risk feedback may represent 
an unintended, and potentially adverse, consequence of providing cancer type-specific 
assessment results. Future research is warranted to replicate these results. In the meantime, 
cancer prevention and risk communication professionals should be cognizant of the potential for 
such spillover effects. 
On the other hand, CRC screening intentions as well as intentions to talk to a doctor about 
CRC screening significantly increased at post-intervention (compared to pre-intervention), again 
regardless of group. This finding suggests that cancer risk assessments may be useful in 
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promoting screening behavioral intentions among average risk individuals regardless of whether 
the content is personalized. Within the control group, mammography screening intentions also 
increased at post-intervention. This is somewhat surprising given both perceived lifetime and 
absolute risk decreased in this group (although the latter did not reach statistical significance). 
This result may indicate that generic feedback on specific risk factors (including screening 
behavior) is more likely to produce spillover intentions on other types of cancer. Findings such 
as these highlight the importance of explicitly test for spillover effects as interventions that can 
successfully change multiple behaviors are likely to be more efficient than those targeting one 
behaviors at a time. 
While results related to screening intentions are encouraging, there were limited effects 
observed on diet and physical activity intentions. The null results related to diet intentions is 
particularly worrisome given that dietary habits are strongly associated with CRC risk and an 
unhealthy diet was the most prevalent risk factor identified in this sample. It is possible that 
screening is perceived differently, i.e., a “one and done” behavior to reduce risk, as opposed to 
an ongoing, daily change in lifestyle. Alternatively, screening was the only negatively-framed 
message; therefore, behavioral intentions of average risk individuals may be influenced more by 
negatively-framed prevention messages, although this would contrast prior work supporting an 
advantage of gain-framed messages on preventive behaviors intentions [41, 50]. Moreover, the 
positive/negative framing of messages only applied to the behaviors regarded as risk factors. The 
presence or absence of risk factors (as defined by participant reported engagement in health 
behaviors) produced variation within the treatment arm personalized messages. Potential 
differences in outcomes associated with the varying message combinations were not evaluated in 
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the present study. It is possible that these differences within the treatment arm muddied our 
ability to detect the effects of personalization. Future research should examine specific forms of 
personalization more closely within defined risk groups. These results underscore the need for 
future research on the role risk information plays in promoting behavior change intentions, and 
in addition, the relative difficulty researchers face in “moving the needle” on lifestyle 
modifications among individuals without a family history of cancer.  
Finally, the null findings between trial arms may be partially explained by the average risk 
(and thus by definition low risk) status of the study sample. Participants were purposefully 
provided with a low numerical risk estimate of less than 5% which may have been judged of 
insufficient magnitude to heighten perceptions of risk. This supposition is bolstered by the fact 
that perceived numeric lifetime risk of CRC decreased in both groups post-intervention. If this 
explanation were true, it would provide a potential caveat to prior research suggesting that 
personalized risk feedback is more successful in motivating changes in lifestyle behaviors [51]. 
However, the single item used to indicate absolute risk significantly increased from pre- to post-
intervention within the treatment group and was approaching statistical significance (t(417) = -
1.874, p = .06), with higher risk reported in the treatment group, compared to control (as 
hypothesized). This result offers some evidence pointing to a potentially beneficial role of 
personalized information in promoting change (via increased non-numeric perception of risk), 
even when provided in combination with average and relatively low estimates of lifetime risk. 
Strengths and Limitations 
A primary limitation of this study was the relative similarity between the treatment and 
control arms. That all participants received a numeric estimate of lifetime risk and information 
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on risk factors may explain the limited changes in the primary outcome (i.e., risk perception). It 
is also possible that the degree of personalization within the treatment arm was not enough. The 
information provided on risk factors could have been further personalized based on participant 
age and race/ethnicity. Enhanced personalization that reinforces the threat of CRC (despite being 
at average risk), combined with clearer differences between the personalized and non-
personalized arms, may be necessary to isolate the effects of personalization when 
communicating information about risk factors to those at average risk.  
In addition, responses from this internet panel sample may not generalize to populations that 
do not engage in online research. Nor do survey responses regarding behavioral intent 
necessarily translate actual behavioral change. The public use of risk assessment tools may be 
influenced by different individual characteristics such as motivations, interests, and readiness to 
change. Finally, the lifetime risk estimates provided in this study were based on the average 
combined lifetime risk of men and women in the United States and were not personalized for 
each respondent. Although the actual estimated range of lifetime risk in an average risk sample 
would be relatively small, providing individualized risk estimates may yield different results. 
Therefore, it may be beneficial to repeat this study with more precise estimates of lifetime risk.  
The limitations of this study are balanced by several strengths. First, the sample is 
economically and racially diverse which enhances the ability to generalize findings to such 
populations, an uncommon trait of internet samples [52]. In addition, the sample consists of 
individuals with average risk for CRC, a relatively understudied, yet critical population to study 
cancer risk assessment and preventive behaviors, since the majority of CRC will occur among 
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individuals without a family history [53]. Finally, the internet survey did not allow respondents 
to skip questions and therefore, there was no need to statistically account for missing data.  
Conclusion 
Taken together, results here highlight the complexity of cancer risk perceptions and suggest 
that cancer risk assessment tools may alter risk perceptions and facilitate behavior change 
intentions, especially screening intentions, among an average risk population. Our findings shed 
new light on the potential utility of cancer risk assessment tools as vehicles to improve the 
accuracy of individuals’ cancer risk perceptions while promoting risk-reducing behaviors.  
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Table 1. Treatment Group Messages 
Behavior Protective Message Risk Message 
 
Screening 
 
You've had one of the colon 
cancer screening tests 
recently. 
 
Get screened for colon cancer 
regularly. If you do not get screened 
doctors will not be able to find and 
remove precancerous polyps before 
they turn into cancer. So, talk to your 
doctor about getting screened. 
Regular screening is the single best 
way to lower your colon cancer risk. 
 
 
Physical Activity 
 
You are physically active. 
 
Increase your physical activity. 
Work towards at least 30 minutes of 
physical activity a day. Being 
physically active can lower your 
colon cancer risk by as much as half. 
  
 
Diet 
 
You eat a diet high in 
vegetables. 
 
Improve your diet. Strive to eat 
more vegetables and less than 3 
servings of red meat a week. A diet 
high in vegetables may help reduce 
your risk of colon cancer. 
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Table 2. Sample Characteristics Overall and by Intervention Arm (N=419) 
Variable 
Overall Control Treatment 
 (n=207) (n=212) 
Demographic Characteristics    
Mean Age (sd) 58.5 (6.3) 58.7 (6.3) 58.3 (6.2) 
Female Gender 279 (66.6) 138 (66.7) 141 (66.5) 
Race    
   White 140 (33.4) 73 (35.3) 67 (31.6) 
   Black 140 (33.4) 64 (30.9) 76 (35.8) 
   Hispanic 139 (33.2) 70 (33.8) 69 (32.5) 
Currently Marrieda 203 (48.4) 106 (51.2) 97 (45.8) 
Income    
   <20k 94 (22.4) 47 (22.7) 47 (22.2) 
   20-49k 145 (34.6) 61 (29.5) 84 (39.6) 
   50-74k 90 (21.5) 50 (24.2) 40 (18.9) 
   75-99k 46 (11.0) 24 (11.6) 22 (10.4) 
   ≥100k 44 (10.5) 25 (12.1) 19 (9.0) 
College Graduate 203 (48.4) 105 (50.7) 98 (46.2) 
Currently Employedb 173 (41.3) 88 (42.5) 85 (40.1) 
Insured 368 (87.8) 182 (87.9) 186 (87.7) 
Colorectal Cancer Risk Factors/Screening    
Mean Targeted Risk Factors/Screening (sd) (0-3)c 1.8 (0.8) 1.8 (0.8) 1.7 (0.8) 
Colorectal Cancer Screeningd 209 (49.9) 104 (50.2) 105 (49.5) 
Physical Activitye 182 (43.4) 89 (43.0) 93 (43.9) 
Inadequate Vegetable Consumptione 348 (83.1) 176 (85.0) 172 (81.1) 
Note. Values represent total number (column percentage) unless otherwise stated. 
a Currently married or living with significant other 
b Currently employed full-time or part-time 
c Includes CRC screening, physical activity and diet risk factors 
d Not up-to-date per guidelines 
e Inadequate per guidelines 
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Table 3. Risk Perceptions and Behavioral Intentions by Group at Pre-Intervention and Post-Intervention (N=419) 
Variable 
Post-Intervention Pre-Intervention Within Groups3 
Control 
(n=207) 
n (%) 
Treatment 
(n=212) 
n (%) 
Between 
Groups1,2       
p 
Control 
(n=207) 
n (%) 
Treatment 
(n=212) 
n (%) 
Control 
 
p 
Treatment              
 
p 
Colorectal Cancer Risk Perceptions        
Perceived Lifetime Risk        
   Mean Percentage (sd) (0-100%) 11.0 (16.6) 11.0 (16.0) 0.999 18.9 (21.1) 17.8 (20.9) 0.000 0.000 
   Accurate Lifetime Risk (N (%))c 92 (44.4) 103 (48.6) 0.396 15 (7.2) 10 (4.7) 0.000 0.000 
Perceived Absolute Risk        
   Mean Absolute Risk (sd)a 2.2 (0.9) 2.4 (1.0) 0.062 2.1 (0.9) 2.2 (1.0) 0.170 0.008 
Perceived Relative Risk        
   Mean Relative Risk (sd)b 2.3 (0.9) 2.2 (1.0) 0.378 2.3 (1.0) 2.3 (1.1) 0.93 0.071 
Behavioral Intentions        
Colorectal Cancer Screening        
   Mean Screening Intention (sd)e 3.0 (1.4) 3.2 (1.5) 0.278 2.7 (1.4) 2.9 (1.4) 0.000 0.000 
   Mean Intention to Talk to Doctor (sd)e 2.9 (1.3) 2.9 (1.4) 0.844 2.6 (1.3) 2.7 (1.3) 0.000 0.000 
Physical Activity        
   Mean Physical Activity Intention (sd)e 3.2 (1.1) 3.2 (1.2) 0.867 3.1 (1.2) 3.1 (1.2) 0.031 0.180 
Diet        
   Mean Diet Intention (sd)e 3.3 (1.2) 3.3 (1.2) 0.917 3.2 (1.2) 3.2 (1.1) 0.175 0.471 
Breast Cancer Risk Perceptions and 
Screening Intentions (n=279 women) 
       
Perceived Absolute Risk        
   Mean Absolute Risk (sd)a 2.4 (1.0) 2.5 (1.0) 0.492 2.5 (1.0) 2.4 (1.1) 0.058 0.154 
Perceived Relative Risk        
   Mean Relative Risk (sd)b 2.6 (1.1) 2.5 (1.0) 0.474 2.6 (1.0) 2.5 (1.1) 0.433 0.347 
Perceived Lifetime Risk        
   Mean Percentage (sd) (0-100%) 22.1 (23.1) 20.6 (24.1) 0.606 26.2 (24.4) 22.5 (24.0) 0.002 0.034 
   Accurate Lifetime Risk (N (%))d 12 (11.2) 14 (12.2) 0.824 15 (14.0) 15 (13.0) 0.629 1.000 
Mammography Screening        
   Mean Mammography Intention (sd)e 3.9 (1.4) 3.8 (1.5) 0.754 3.7 (1.4) 3.7 (1.4) 0.032 0.338 
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Note. 
1 Between groups: post-test only comparison between treatment vs. control (independent samples t-tests and chi-squared test of association) 
2 Analyses controlling for pre-test values were performed and did not produce different outcomes.   
3 Within groups: pre-test vs. post-test (paired samples t-tests and McNemar's tests) within each group (control and treatment) 
a Item measured on a 5 point Likert scale, Very Unlikely (1) to Very Likely (5) 
b Item measured on a 5 point Likert scale, Much Lower (1) to Much Higher (5) 
c Between 4-5% coded as accurate 
d Between 10-15% coded as accurate 
e Item measured on a 5 point Likert scale, Not At All (1) to Extremely (5)
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Figure 1. Lifetime Risk for Colorectal Cancer 
 
Note. Figure 1 depicts lifetime risk for men (A) and women (B). 
A 
B 
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Figure 2. Control Group Risk Factory Message 
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Figure 3. Treatment Group Risk Factor Messages 
  
Note. Figure 3 depicts risk factors framed as risk (A) and protective (B) factors. 
A 
B 
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Footnotes 
1 Qualtrics outsourced recruitment to partner companies with established panels. 
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CHAPTER 3 
Paper Two 
POST RISK ASSESSMENT COLORECTAL CANCER LIFETIME RISK ACCURACY AND 
BEHAVIOR CHANGE INTENTIONS 
Abstract 
Background 
Accurately gauging risk may be an important factor in promoting preventive health 
behaviors. Cancer risk assessment can improve risk perception accuracy, but little is known 
about how improved accuracy affects health behavior change intentions within the average risk 
population.  
Purpose 
The purpose of this study was to examine accuracy of perceived lifetime risk of CRC prior 
to and immediately following receipt of CRA feedback within a sample of average risk adults. 
We also assessed whether improvement in perceived lifetime risk accuracy was associated with 
changes in behavior change intentions for physical activity, diet and attending CRC screening. 
Methods 
Data were collected as part of a pre-post parallel design randomized controlled trial 
examining the impact of CRC cancer risk assessment (CRA) feedback. Adults aged 50-75 years 
with no personal or family history of CRC (N=419) were enrolled in the parent study. 
Participants’ colorectal cancer risk perceptions and behavioral intentions were ascertained 
immediately before and after risk assessment administration.  
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Results 
Accuracy of perceived lifetime risk significantly improved after CRA feedback. Those who 
were White (compared to Black or Hispanic), married, college educated (compared to college 
graduates) and had higher numeracy were more likely to report accurate lifetime risk post-CRA. 
No differences in behavioral intentions were reported between those with improved accuracy and 
those who remained inaccurate post-CRA. 
Conclusion 
CRAs can significantly improve perceived lifetime risk accuracy among those at average 
risk. Although improved accuracy was not associated with increased behavioral change 
intentions, it is reassuring that improved accuracy (via a decrease in perceived risk) did not 
inhibit (reduce) intentions for health behaviors. 
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Background 
Although CRC incidence is relatively low within the U.S. population, it is not a negligible 
threat and should not be dismissed. Colorectal cancer (CRC) is the third most commonly 
diagnosed cancer among men and women in the United States (US) and the second leading cause 
of cancer deaths overall [1]. Approximately 50,000 deaths were estimated to occur from the 
disease in 2017 [1]. CRC risk can be reduced through regular screening and lifestyle 
modification, such as improving diet and physical activity [2-4]. In fact, it has been estimated 
that as much as 70% of CRC cases could be prevented through lifestyle modification and 
widespread screening [5]. However, roughly 32 million Americans believe nothing can be done 
to reduce an individual’s cancer risk [6]. Informing the public on disease risk and the modifiable 
risk factors for CRC may be an important first step in motivating changes in lifestyle and other 
risk-reducing behaviors, such as cancer screenings. Numerous theories of health behavior 
provide rationale for using risk information to promote cancer prevention, postulating that 
increasing an individual’s perception of risk will lead to behavioral changes to reduce risk [7-9].  
Cancer risk prediction models and assessment tools, hereafter referred to as cancer risk 
assessments (CRAs), have been developed to convey risk information and inform prevention 
strategies. Although CRAs are typically used for those at increased risk in the clinical setting, 
CRAs have the potential to inform prevention strategies across the spectrum of cancer risk [10]. 
A systematic review of trials using CRAs in primary care (n=11) suggests potentially beneficial 
effects of risk assessment feedback in accuracy of risk perceptions and screening intentions, 
without increasing cancer-related anxiety [11]. However, the relatively small evidence base in 
this review was heterogeneous in terms of cancer and intervention type and included studies 
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targeting groups with existing concerns about their risk due to family history. Within CRC 
specifically, population level approaches to risk reduction would yield highest benefits, since 
approximately 70% of CRC cases occur in patients with no family history of the disease (i.e., 
“average risk” individuals) [12]. However, little is known about the application of CRAs for 
population approaches to cancer prevention (i.e., targeting the whole population, not only those 
at high risk), or the psychosocial and behavioral impact of CRA feedback on average risk 
individuals, who represent the majority of colorectal cancer cases. 
Despite the threat, perceptions of CRC risk are low in the general population [13-15] and 
often incorrectly estimated in average risk research samples [16-17]. Accurately gauging risk 
may be an important factor in promoting preventive health behaviors within the average risk 
population who may not receive as compelling of behavioral recommendations as those 
identified as high risk. Previous research has suggested that providing personalized CRC 
absolute and relative risk estimates improves the accuracy of these risk perceptions among older 
adults with no personal history of cancer [16-17]. Categorical relative risk estimates (e.g., 
“average risk”) and absolute risk estimates (e.g., “x chances in 1000”) over a 20-year period 
were provided in these studies. However, an estimate of the accumulated risk over a lifetime may 
provide more valuable information to adults with average CRC risk. Specifically, being informed 
that your lifetime risk of developing CRC is between 4-5%, may elicit different risk perceptions 
and behavior change intentions than other risk presentation formats. It is unclear whether the 
provision of CRA results will improve lifetime risk perceptions among individuals with no 
personal or family history of CRC and whether improved accuracy of lifetime risk is beneficial 
among those at average risk. Moreover, it is not known if improved accuracy of lifetime risk 
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increases uptake of preventive health behaviors or alternatively could contribute to ambivalence 
or discourage the adoption of lifestyle change behaviors. 
The present research study examined individuals’ accuracy of perceived lifetime risk of 
CRC prior to and immediately following receipt of CRA feedback within a sample of average 
risk adults. The aims of this study were to: characterize perceived lifetime risk prior to CRA 
feedback; examine predictors of baseline perceived lifetime risk accuracy and identify predictors 
of improved risk perceptions among those who were inaccurate at baseline. A final question 
assessed whether improvement in perceived lifetime risk accuracy was associated with changes 
in behavior change intentions for physical activity, diet and attending CRC screening. 
Methods 
Study Design 
Data for this study was collected as part of an IRB approved randomized controlled trial 
examining the impact of CRA feedback on perceived risk and behavioral intentions using a pre-
post parallel trial design.1 As part of that parent study the participants were randomized to one of 
two arms receiving colorectal cancer risk results including a population-based estimate of 
average lifetime risk according to gender (4.7% for men and 4.4% for women) and information 
about CRC risk factors that was either invariant and non-personalized (arm one) or personalized 
recommendations based on respondent reported risk factors (arm two). No effects for 
intervention arm on risk perceptions or behavioral intentions were found in the parent study. For 
the purposes of this study, intervention arm was used as a covariate in regression analyses.  
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Sample and Survey Administration 
The target population for the study was adults, aged 50-75 years, with no personal or family 
history of colorectal cancer, or known predisposition or condition (e.g., inflammatory bowel 
disease, polyps or a hereditary syndrome such as familial adenomatous polyposis (FAP) or 
hereditary nonpolyposis colon cancer (HNPCC), also known as Lynch Syndrome). The sample 
was also limited to English-speaking residents of the contiguous United States. 
The study was conducted using Qualtrics, a leading online survey research company, in June 
2017. Participants were recruited from existing participant panels.2 Panelists were invited to 
participate using a double opt-in process. Potential participants received an email invitation 
informing them about the study and providing a link to the study consent form and survey. Quota 
sampling was used to obtain a sample balanced by race/ethnic identity (White, Black/African 
American and Hispanic/Latino/Spanish origin) and representative ranges of annual household 
incomes. Participants received the equivalent of approximately $5.00 remuneration for 
participation. Survey items measured numeracy, socio-demographic characteristics (e.g., age, 
gender, race, education, marital status, and employment status), and baseline health behaviors 
(e.g., physical activity, vegetable consumption, and CRC screening), as well as risk perception. 
Outcome Measures 
Lifetime Risk Accuracy. 
Perceived lifetime risk was assessed at pre- and post-CRA with a single item, “On a scale 
from 0 to 100 %, how would you rate the probability that you will develop colorectal cancer in 
the future?” with an open-response of 0-100%. A dichotomous measure of lifetime risk accuracy 
was created that defined ‘accurate’ as a response between four and five percent, according to 
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statistics from the American Cancer Society [18]. A binary variable was also created to indicate 
those with improved lifetime risk accuracy at post-CRA (i.e., those with an inaccurate perception 
at pre-CRA and an accurate perception at post-CRA). 
Behavioral Intentions. 
Behavior change intentions related to colorectal cancer screening, diet and physical activity 
were measured at pre- and post-CRA. Based on previous CRC screening research [19], 
respondents were asked a single item adapted for each behavior, “How likely are you to [get 
screened for colorectal cancer, improve your diet, and increase your physical activity] in the next 
6 months?” with a five-point Likert response scale of “not at all to “extremely.” Participants 
classified as up-to-date on screening (per self-reported screening behavior) were asked about 
screening intentions using an alternative ending, “…when you are due to screen again?”   
Analyses 
Paired samples McNemar's tests were used to assess differences in the proportion of 
participants with an inaccurate lifetime risk perception at pre- and post-CRA. Adjusted logistic 
regression models were estimated to assess (1) predictors of pre-CRA lifetime risk accuracy and 
(2) predictors of post-CRA improvement in lifetime risk accuracy among those who were 
inaccurate at pre-CRA while controlling for pre-CRA accuracy level (i.e., overestimate or 
underestimate). Those with an accurate perception of lifetime risk at pre-CRA were excluded 
from the latter regression analysis. Behavioral intentions were assessed between those with 
improved lifetime risk accuracy and those who remained inaccurate at post-CRA using five-point 
Likert scales. When regarded as continuous outcomes, independent samples t-tests were used to 
test for differences in behavioral intentions. Differences in the proportion of participants that 
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increased behavioral intentions from pre- to post-CRA were assessed using chi-squared tests of 
association. Analyses were performed using SPSS version 24.    
Results 
Sample Characteristics 
Among the 1,606 panelists that initiated participation (i.e., clicked on the survey link and 
completed the consent page), 158 declined, 671 did not meet study eligibility criteria and an 
additional 220 screened out due to quota sampling. Seventy-one respondents did not complete 
the survey and an additional 67 were removed from the study for failing an attention check (i.e., 
one of three survey items that required specific responses). A total of n=419 eligible participants 
were included in this analysis.  
Participants were 58.5 years old on average (sd=6.3). Sixty-seven percent of the sample 
were female (n=279). As designed, the sample included equal proportions of White, Black, and 
Hispanic participants (33% each). Almost half of respondents were married (48%) and college 
educated (48%). Less than half were employed (41%) and 43% reported an annual household 
income of $50,000 or higher. On average, respondents correctly answered 2.4 (sd=1.2) of the 
five numeracy questions accurately. Sample characteristics are presented in Table 1. 
Pre-CRA Lifetime Risk 
The average perceived lifetime risk of CRC reported at baseline (pre-CRA) was 18% 
(sd=21.0); responses ranged between 0 and 100%. As shown in Table 2, few participants (n=25) 
had an accurate perception of their lifetime risk of CRC. The majority of participants 
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overestimated (57%) or underestimated (38%) their lifetime risk prior to receiving CRA 
feedback. 
Predictors of Pre-CRA Lifetime Risk Accuracy 
Results from an adjusted logistic regression indicated that those currently employed were 
less likely to report lifetime risk accurately at baseline (see Table 3). No other factors were 
associated with baseline lifetime risk accuracy in this model controlling for numeracy and study 
arm. 
Predictors of Improved Post-CRA Lifetime Risk Accuracy 
The overall average perceived lifetime risk reported post-CRA was 11% (sd=16.3); 
responses ranged between 0 and 95%. As shown in Table 2, n=195 participants had an accurate 
perception of their lifetime risk for colorectal cancer post-CRA (47%). The proportion of 
participants with an accurate perception of lifetime risk significantly increased from pre to post 
(χ2(1) = 148.755, p < .001). Concurrently, the proportions of participants underestimating and 
overestimating their lifetime risk significantly decreased from pre- to post-CRA (χ2(1) = 33.307, 
p < .001 and χ2(1) = 73.333, p < .001 for underestimating and overestimating, respectively). 
Among the n=394 participants with an inaccurate perception of lifetime risk at pre-CRA, 
n=181 improved their perception of lifetime risk from inaccurate to accurate at post-CRA (χ2(1) 
= 179.006, p < .001). Table 4 presents results of the logistic regression analysis testing the role of 
participant characteristics, controlling for numeracy, pre-CRA accuracy level, and study arm, on 
improved accuracy of lifetime risk at post-CRA. Whites (compared to Blacks and Hispanics), 
those who were married, those with some college education (compared to college graduates) and 
higher numeracy had a higher likelihood of reporting an accurate lifetime risk post-CRA. The 
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likelihood of lifetime risk accuracy at post-CRA was not statistically different between those 
with a high school degree or less education and those with a college degree. 
Post-CRA Improved Lifetime Risk Accuracy and Behavioral Intentions 
The behavioral intentions of participants who improved lifetime risk accuracy from pre to 
post were not significantly different from those that remained inaccurate at post-CRA. As shown 
in Table 5, there were no differences in the mean behavioral intentions for screening, diet and 
physical activity at post-CRA between those who improved accuracy and those who remained 
inaccurate (left side of table). Similarly, no differences were observed in the proportion of 
participants that increased their behavior change intentions for any behavior from pre to post 
between those with an improved perception of lifetime risk and those who remained inaccurate at 
post-CRA (right side of Table 5). 
Discussion 
In order to understand who stands to benefit from receiving cancer risk information, this 
study identified predictors of CRC perceived lifetime risk accuracy prior to and following CRA 
feedback. The analysis of predictors of post-CRA perceived lifetime risk accuracy revealed 
higher likelihood of accuracy among Whites (compared to Blacks and Hispanics), the married, 
those with some college (compared to college graduates) and higher numeracy. One of the more 
interesting findings is that instead of revealing who is most likely to benefit from CRA feedback, 
results implied meaningful information about who was less likely to benefit. In particular, we 
found lower post-CRA accuracy was more likely among minorities and individuals with low 
numeracy. Higher proportions of Blacks and Hispanics continued to underestimate (29% and 
24%, respectively, compared to 17% Whites) and overestimate (37% and 34%, respectively, 
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compared to 21% Whites) their risk post-CRA. Understanding what is driving the differences 
within these traditionally underserved subgroups of the population could help inform the 
development of more effective risk communication strategies. Previous research using national 
data has observed lower cancer risk perceptions among Blacks and Hispanics compared to 
Whites [20-22]. At least one study has speculated that racial differences in awareness of family 
history of cancer may account for observed differences in cancer risk perception [21]. However, 
our results suggest that racial differences in risk perception persist within a sample consisting 
entirely of individuals reporting no known family history of CRC. Risk perceptions may also be 
influenced by medical mistrust and different health attitudes and perceptions among minority 
groups [23]. The finding that those who had low numeracy scores are less likely to have accurate 
lifetime risk perception post-CRA is not surprising since previous research has supported an 
association between numeracy and the perception of health risks [24]. Since a basic numeric 
proficiency is required to understand cancer risk information [25], our results suggest that 
communicating risk information that accommodates varying numeracy levels may be important. 
As long as disparities in CRC incidence and mortality persist, greater attention is warranted to 
understand whether and how risk perception inaccuracies contribute to these disparities and how 
best to address these perceptions. [26]. 
Results of the analysis of predictors of pre-CRA accuracy indicated that currently employed 
individuals were significantly less likely to have perceived lifetime risk accuracy, compared to 
those not currently employed. Although this is an unexpected finding it should be interpreted 
with caution as only 6% of participants accurately reported lifetime risk of CRC at pre-CRA. A 
larger sample size may be necessary to establish a better understanding of baseline predictors of 
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lifetime risk accuracy and subsequently, to characterize those who may be most in need of CRA 
feedback. Moreover, the proportion of employed adults in this sample is somewhat lower than 
the proportion of employed adults in the U.S. population of adults aged 50-75 years (41% versus 
53%, respectively) [27]. Future research is needed to determine how generalizable internet 
samples are to the population and to other research samples using different sampling strategies, 
especially when targeting older adults. 
An examination of improvements in lifetime risk perception and behavior change intentions 
revealed no differences in intentions between those with an accurate versus inaccurate lifetime 
risk perception at post-CRA. It may be that accuracy of lifetime risk perception is not a 
significant precursor to the adoption of preventive behaviors or, in this case, it may be that 
having accurate knowledge of the average lifetime risk of CRC is not a salient catalyst to 
produce health behavior change intentions. Considering that knowledge alone is considered 
necessary but not sufficient to change behavior, additional studies should focus on developing 
effective messages in the context of CRA to emphasize not only that those at average risk are 
still at risk but also to encourage health behavior change to reduce risk and prevent disease. For 
example, rather than emphasizing the accuracy of lifetime risk, which at 5% is rather low, public 
health messaging can focus on the benefits of prevention and early detection behaviors in terms 
of the proportion of cases prevented. 
Strengths and Limitations 
By exploring whether risk perception accuracy was associated with behavior change 
intentions, this study helped fill a gap in the existing literature base. Although improved accuracy 
was not associated with positive behavioral intentions as expected, that intentions did not 
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decrease when perceived risk lowered provides novel information. Results also point to future 
directions for research. The items assessing lifestyle behavioral intentions were possibly phrased 
too broadly. Asking specifically about intentions to increase intake of fruits and vegetables or 
reduce red meat consumption, for example, may have produced different outcomes than asking 
about intentions to “improve your diet.” Another potential limitation of the present research is 
that we did not fully capitalize on having a racially/ethnically diverse sample. Providing 
culturally-sensitive personalized messages by racial/ethnic group could better promote behavior 
change intentions and therefore, should be incorporated in future studies examining CRA 
feedback. 
Conclusion 
Very few participants had an accurate understanding of lifetime risk for CRC at baseline. 
Although the percentage of participants with accurate lifetime risk significantly increased 
following CRA feedback, more than half of participants remained inaccurate. This demonstrated 
lack of awareness of CRC risk is concerning. Minorities and those with low numeracy were more 
likely to report inaccurate perceptions post-CRA, highlighting well-documented disparities in 
risk perception and the comprehension of complex, numerical information. Although accuracy at 
post-CRA was not associated with increased behavioral intentions, it is reassuring that improved 
accuracy (often via a decrease in perceived risk) was not associated with lower health behavior 
intentions. In conclusion, accuracy of perceived lifetime risk is just one facet of potential 
outcomes to examine following CRA. Additional research is needed to improve post-CRA 
accuracy and understanding among minority and low numeracy groups, including testing risk 
communication strategies conveying risk information tailored to an individual’s race and 
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numeracy. Future public health efforts should continue to explore the potential utility of CRAs to 
promote cancer prevention in both high and average risk groups. 
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Table 1. Sample Characteristics (N=419) 
Variable n (%) 
Mean Age (sd) 58.5 (6.3) 
Female Gender 279 (66.6) 
Race  
   White 140 (33.4) 
   Black 140 (33.4) 
   Hispanic 139 (33.2) 
Currently Marrieda 203 (48.4) 
Income  
   <20k 94 (22.4) 
   20-49k 145 (34.6) 
   50-74k 90 (21.5) 
   75-99k 46 (11.0) 
   ≥100k 44 (10.5) 
College Graduate 203 (48.4) 
Currently Employedb 173 (41.3) 
Mean Numeracy (sd) (0-5) 2.4 (1.2) 
Note. 
a Currently married or living with significant other 
b Currently employed full-time or part-time 
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Table 2. Accuracy Level of Perceived Lifetime Risk of CRC at Pre- and Post-CRA (N=419) 
 
Accuracy Level 
Pre-CRA 
(n (%)) 
Post-CRA 
(n (%)) 
 
p 
Underestimated 157 (37.5) 98 (23.4) <0.001 
Accurately Estimated 25 (6.0) 195 (46.5) <0.001 
Overestimated 237 (56.6) 126 (30.0) <0.001 
  
  
 
 
 
 78 
Table 3. Adjusted Logistic Regression: Pre-CRA Perceived Lifetime Risk Accuracy (N=419)  
Variable 
Pre-CRA Accurate Lifetime Risk Perception 
B SE B Wald df Exp(B) 
95% CI for 
EXP(B) 
Lower Upper 
Numeracy 0.151 0.162 0.864 1 1.163 0.846 1.598 
Age (years) -0.002 0.035 0.004 1 0.998 0.932 1.068 
Male Gender (ref: Female) -0.239 0.471 0.258 1 0.787 0.313 1.982 
Race (ref: White)        
   Black  -0.289 0.560 0.266 1 0.749 0.250 2.244 
   Hispanic -0.001 0.525 0.000 1 0.999 0.357 2.797 
Married (ref: Not Married) 0.186 0.436 0.182 1 1.205 0.512 2.835 
Education (ref: College 
Graduate)        
   High School Degree or Less -1.146 0.693 2.738 1 0.318 0.082 1.236 
   Some College 0.414 0.490 0.714 1 1.513 0.579 3.953 
Employed (ref: Not Employed) -1.557 0.586 7.066 1 0.211 0.067 0.664 
Study Arm (ref: Control) -0.405 0.433 0.874 1 0.667 0.285 1.559 
(Constant) -2.194 2.281 0.926 1 0.111   
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Table 4. Adjusted Logistic Regression: Post-CRA Improved Perceived Lifetime Risk Accuracy 
(n=394) 
Variable 
 Post-CRA Accurate Lifetime Risk Perception 
B SE B Wald df Exp(B) 
95% CI for 
EXP(B) 
Lower Upper 
Numeracy 0.314 0.085 13.671 1 1.369 1.159 1.616 
Age (years) -0.009 0.019 0.239 1 0.991 0.955 1.028 
Male Gender (ref: Female) -0.053 0.241 0.049 1 0.948 0.591 1.522 
Race (ref: White)        
  Black -0.970 0.287 11.397 1 0.379 0.216 0.666 
  Hispanic -0.718 0.274 6.859 1 0.488 0.285 0.835 
Married (ref: Not Married) 0.545 0.226 5.814 1 1.724 1.107 2.685 
Education (ref: College 
Graduate)        
  High School Degree or Less -0.385 0.278 1.925 1 0.680 0.395 1.172 
  Some College 0.586 0.299 3.850 1 1.797 1.001 3.227 
Employed (ref: Not Employed) 0.048 0.240 0.040 1 1.049 0.656 1.679 
Pre-CRA Overestimate (ref: 
Underestimate) 0.393 0.234 2.825 1 1.481 0.937 2.342 
Study Arm (ref: Control) 0.231 0.223 1.075 1 1.260 0.814 1.950 
(Constant) -0.458 1.243 0.136 1 0.633   
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Table 5. Behavioral Intentions by Post-CRA Perceived Lifetime Risk Accuracy (n=394) 
 
 
Behavior 
Mean Intentions (sd)  
 
p 
Increased Intentions (n (%))  
 
p 
Improved 
(n=181) 
Inaccurate 
(n=213) 
Improved 
(n=181) 
Inaccurate 
(n=213) 
Screening 3.22 (1.5) 3.00 (1.5) 0.135 46 (25.4) 69 (32.4) 0.129 
Diet 3.25 (1.1) 3.33 (1.3) 0.512 39 (21.5) 57 (26.8) 0.230 
Physical 
Activity 
3.22 (1.1) 3.21 (1.2) 0.972 42 (23.2) 58 (27.2) 0.360 
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Footnotes 
1 Detailed study procedures can be found in Paper 1. 
2 Qualtrics outsourced recruitment to partner companies with established panels. 
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CHAPTER 4 
Paper Three 
ONLINE PANEL SAMPLE RECRUITMENT AND CHARACTERISTICS: AN ANALYSIS 
OF THOSE WHO INITIATE VERSUS COMPLETE AN INTERNET SURVEY 
Abstract 
Background 
Using online research panels can be a quick and efficient means of sample acquisition and 
data collection. Despite this strength, there is often a lack of transparency in the recruitment of 
panelists and insufficient consideration of how samples derived from online panels compare to 
relevant populations and other research samples. 
Purpose 
The purpose of this study was to inform researchers on what to expect when administering 
an online survey and recruiting participants using quota sampling through a commercial research 
panel. The sociodemographic characteristics of those who completed the survey were compared 
to those who initiated but did not complete it. The survey exit point of non-completers was also 
examined. 
Methods 
A total of N=419 eligible respondents completed an online survey administered via 
Qualtrics. In addition to study-specific eligibility criteria, sampling quotas were implemented for 
race and income. 
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Results 
The majority of panelists who provided consent and were eligible for participation went on 
to complete the survey. The sociodemographic profiles were similar between survey completers 
and eligible respondents who initiated but did not complete the survey. Survey completers were 
relatively similar to the U.S. population 50+ years old. Subtle differences were noted in marital 
status, income, education, and employment status, but were likely related to the derived sample 
being more racially and economically diverse. Other implications for the use of quota sampling, 
the placement of key items, and survey length were discussed. 
Conclusion 
Quota sampling from an online panel can effectively produce a targeted and diverse sample 
with reasonable internal and external validity. 
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Background 
Increased use of online (internet) surveys has led to a rise in commercial survey and market 
research platforms. Companies such as Qualtrics (www.qualtrics.com), Survey Monkey 
(www.surveymonkey.com), and Amazon’s Mechanical Turk (MTurk; www.mturk.com) allow 
researchers to develop, test, and distribute surveys online. In addition to creating electronic 
surveys for distribution through typical sample outlets, these companies enable researchers to 
purchase access to existing pools of potential participants that have agreed to be solicited for 
survey recruitment. Utilizing online research panels for sample acquisition and data collection is 
quick and efficient. Compared to traditional survey modes (e.g., mail and telephone), online 
surveys are typically less expensive [1] and growing evidence suggests that samples recruited 
through online panels can be as representative of the population as traditional recruitment 
methods [2-4]. 
Online research panels can be particularly effective in targeting specific groups, such as 
respondents who meet a specific condition of interest to the researcher. The use of quota 
sampling (i.e., a non-probability sampling technique) in online panel research can help 
researchers obtain survey participants matching specified criteria, such as employed adults or 
young women aged 18-24 years. Although these are clear advantages, concerns about validity of 
commercially derived online panel samples have been raised [5-7]. 
Potential threats to validity come from a variety of sources. Online panel members are 
recruited from a variety of sources [2] and therefore, precise information on how sampling 
frames are constructed is usually not available. Selection bias may threaten the external validity 
of online panels if, for example, panel participants are substantively different than the population 
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of interest. In addition, racial minorities, older adults, and those with lower levels of educational 
attainment and income are less likely to have broadband internet service [8]. Although lower 
income populations may have internet access through a smartphone [9], prior research has shown 
few panel respondents use smartphones to complete online surveys accessible through multiple 
platforms (e.g., PC, laptop, tablet, and smartphone) [10]. Online panel samples are also subject to 
panel bias whereby panelists’ responses may change based on their participation in the panel 
[11]. Because of these potential drawbacks and the relative lack of control researchers have over 
sample acquisition procedures, a characterization of who panel participants are, how they are 
recruited, and whether there are differences in those who complete and do not complete an online 
survey is needed to inform researchers on the validity of online sample panels. 
To better understand the treats to validity of these panels, we describe the recruitment and 
sampling process of an internet-based survey and evaluate the sociodemographic characteristics 
of the online sample. The specific aims of this study are as follows: (1) to describe the 
recruitment and participant flow of a survey administered by a commercial research platform 
using quota sampling; (2) to describe the sociodemographic characteristics of eligible 
respondents that complete the survey and respondents that initiate, but do not complete the 
survey; (3) to compare sociodemographic profiles of survey completers to respondents who 
initiate, but do not complete the survey; and (4) to determine when study-eligible non-completers 
exit the survey. 
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Methods 
Study Design 
The current study followed the pre-post parallel trial design of a previously described study 
that manipulated the type of information on risk factors (personalized versus generic) for 
colorectal cancer survey respondents received in addition to average risk estimates.1 The data 
reported in this study were collected according to the IRB-approved protocol. The survey 
contained 133 items with each item requiring a response. Completed survey duration ranged 
from 10 to 1,922 minutes, with a median duration of 26 minutes. Data collection occurred over a 
period of 12 days in June 2017 via an internet survey administered by Qualtrics. 
Sample and Survey Administration 
Qualtrics recruited the sample from existing pools of research panel participants.2 
Recruitment targeted potential survey respondents who were likely to qualify based on the 
demographic characteristics reported in their user profiles (e.g., race and age). Panelists were 
sent an email invitation with a unique survey link to the study consent form and survey 
instrument. To be eligible to participate, respondents had to report being between the ages of 50 
and 75 years; no personal or family history of colorectal cancer or other predisposing condition; 
reading and comprehending English; and residing in the contiguous United States (U.S.). 
Sampling quotas were implemented for race and annual household income. Specifically, a 
balanced proportion of respondents with non-Hispanic White, non-Hispanic Black/African 
                                                 
1 Detailed study procedures can be found in Paper 1. 
 
2 Qualtrics outsourced recruitment to partner companies with established panels. 
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American, and Hispanic/Latino/Spanish origin racial/ethnic identities and diversity in reported 
household income (approximately 20% less than 20k, 30% between 20-49k, 20% between 50-
74k, 10% between 75-99k = 10% and 20% greater than or equal to 100k) were requested. 
Respondents identifying as some other race, ethnicity or origin were not eligible to participate. 
Ineligible respondents were immediately exited from the survey upon providing a response that 
did not meet inclusion criteria or exceeded set quotas (i.e., a priori quotas for race or household 
income group already met). We also removed participants from the sample if they responded 
incorrectly to any of three “attention checks” included in the survey (i.e., items that instructed 
respondents to provide a specific response). 
Results 
Recruitment and Participant Flow 
Survey recruitment and participant flow is depicted in Figure 1. The survey was distributed 
to approximately 63,500 panelists based on target demographics, from which 3,178 interacted 
with the survey (i.e., clicked on the survey invitation and/or survey link). Among those who 
interacted with the survey, 1,606 completed the consent page. Of these panelists, 158 did not 
consent (10%), 671 did not meet eligibility criteria (42%), the majority of whom were ineligible 
due to health history (n=574 reported a history of colorectal cancer or other predisposing 
condition). Another 220 respondents screened out due to being over quota (14%). Seventy-one 
respondents did not complete the survey entirely (4%) and an additional 67 were removed from 
the study for failing an attention check (i.e., one of three survey items that required specific 
responses) (4%). A total of n=419 eligible panelists completed the survey (26% of those who 
completed the consent page). 
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 A priori income quotas proposed for this study were not fully implemented. Due to 
difficulties acquiring participants who reported an annual household income of ≥100k, we 
elected to eliminate the income quota after two weeks of data collection. To ensure acquiring the 
overall sample size required to meet a priori determined criteria for statistical power for the 
parent study (i.e., n=400), we used natural probability sampling to obtain the remaining number 
of participants. Ultimately, the final sample consisted of 11% of respondents with ≥100k 
reported income instead of the 20% initially proposed. 
Sample Characteristics 
As shown in Table 1, the average age of the n=419 respondents who completed the survey 
was 58.5 years (sd=6.3). The sample consisted of n=279 females (67%) and as intended, an equal 
proportion of White, Black, and Hispanic respondents (33% each). Approximately one half of 
those completing the survey was married (48%), and an equal proportion was college educated 
(48%). Slightly less than half were employed full or part time (41%). Similarly, slightly less than 
half reported an annual household income of $50,000 or higher (43%). 
In addition to survey completers, Table 1 provides the available sociodemographic 
characteristics for the four types of respondents who consented but did not complete the survey 
(i.e., survey non-completers). Non-completers are categorized as: (1) incomplete due to drop out; 
(2) quality fail (i.e., failed one or more attention check); (3) over quota; and (4) ineligible (i.e., 
did not meet study inclusion criteria related to health history, race, and age). There was a 
variable amount of missing data within the non-completer groups as presented in Table 1, 
depending on when the respondent exited the survey. For example, a respondent over quota due 
to race/ethnicity (item 4) was missing data for age (item 5) and all items thereafter, while a 
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respondent quota due to income (item 10) had complete data for all variables described in Table 
1. 
Additional sample characteristics available on survey completers are presented overall and 
by racial/ethnic group in Table 2. Black respondents had lower numeracy scores on average and 
were less likely to be married (34%) relative to White and Hispanic respondents (53-59%). 
White respondents reported higher income levels and education attainment than minority groups. 
Hispanics had a higher proportion of currently employed respondents (47%) than the other 
groups (37-40%). 
Comparisons of Completers and Non-Completers 
Age. 
Qualtrics was able to recruit panelists within the targeted age range reasonably well. Ages 
within the overall sample ranged from 50-75 years; however, more than half were between 50-60 
years old (65%). Only 4% were 71 years and older. The average age of respondents was similar 
across all groups, ranging from 57 to 62 years. As shown in Figure 1, only n=24 respondents did 
not meet inclusion criteria for age. Among study-eligible respondent groups (i.e., complete, 
incomplete, and quality fail), a one-way ANOVA revealed no significant differences in age (F=2, 
550)=1.804, p=0.166. 
Gender. 
Natural probability sampling resulted in more female respondents than males. The 
proportion of female respondents was consistently high and similar across all respondent groups, 
ranging from 66% to 72% female. Among eligible respondents, a chi-square test of 
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independence was conducted and found no differences in gender by completion status 
(X2(2)=2.005, p=0.367). 
Race. 
Because the proportion of White, Black, and Hispanic respondents who completed the 
survey was determined by set quotas, we did not compare this group to others on this criterion. A 
chi-square test of independence between racial group and the two eligible non-completer groups 
(i.e., incomplete and quality fail), however, found no statistically significant associations 
(X2(2)=2.272, p=0.321).  
The proportion of White respondents was markedly higher in the over quota group relative 
to other groups (92% versus 20-35%, respectively). This difference results from the use of 
sampling quotas for race and suggests that the quota for White respondents was met before the 
quotas for Black and Hispanic respondents. 
Income. 
Quota sampling was also used to influence the dispersion of reported incomes for survey 
completers. Therefore, it would not be appropriate to compare completers to non-completers on 
income. However, a one-way ANOVA was performed between the incomplete and quality fail 
groups and revealed no statistically significant differences in income, (F=1, 121)=0.637, 
p=0.426. There was insufficient data available to describe the ineligible non-completers. 
Non-Completer Survey Exit Points 
A summary of when study-eligible survey non-completers (i.e., incomplete and quality fail) 
exited the survey is presented in Table 3. As shown on the top, 21% of the non-completer group 
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did not progress beyond the initial survey screener items (i.e., “early drop outs”). An additional 
59% of the non-completers dropped out during the first half of the survey (prior to receiving risk 
assessment feedback). These results may indicate the survey was too long to retain interest and 
engagement for some participants. The remaining 20% of non-completers exited after 
completing more than half of the survey.  
Table 3 also shows a breakdown of the specific items within the screening and pre-test risk 
perception/health behavior sections, the top areas where incomplete survey respondents exited, 
which accounted for a combined 58% of the total group. Within the screening section, most 
stopped completing the survey during health history items. Among those who exited within the 
pre-test risk perception/health behavior section, respondents were most likely to exit from an 
item assessing risk perceptions. 
Within the quality fail group (see bottom half of Table 3), comprised of study-eligible 
respondents who failed one of the three attention items, approximately one-quarter failed the first 
item (28%) and one-quarter failed the second item (22%). Nearly one-half failed the third 
attention check (49%). 
Discussion 
This study informs researchers on what to expect when administering an online survey and 
recruiting participants through a commercial research panel. A thorough description of how 
quota sampling was used to obtain a racially and economically diverse sample of older adults in 
a relatively short period of time was provided. Sociodemographic characteristics overall, as well 
as within and between respondent groups, were examined and provided several indicators of 
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reasonable sample internal validity. Results provide context and suggestions for future 
researchers contemplating the use of commercially administered research surveys. 
The level of transparency regarding recruitment and participant flow reported in this study 
(e.g., # emailed, # interacting with the survey, analysis of over quota exclusions, etc.) is greater 
than that typically reported in other recent studies using online research panels [12-13]. The 
information outlined indicates that commercial research platforms have access to large panels of 
research participants. Although more than 60,000 panelists were sent a survey invitation, half of 
those who interacted with the email ultimately completed the consent page of the survey. Among 
those who consented and were eligible for participation, most completed the survey (75%). For 
internet derived samples, this ‘completion rate’ (i.e., the proportion of survey completers out of 
all eligible respondents who initiate the survey) is more meaningful than a traditional response 
rate as unique factors influence panel response that may not be quantifiable by researchers (e.g., 
inactive panel members and invalid emails) [14]. Health history was the primary reason for 
ineligibility – a study-specific inclusion criterion. Collectively, these findings indicate that 
despite contacting higher numbers of potential participants relative to traditional methods, online 
sampling can target participants based on specific age and race parameters well. 
The sociodemographic characteristics of survey completers were consistent with the study 
inclusion criteria and set quotas (except for the highest income level). Study-eligible respondent 
groups were similar in age and gender and no significant differences were identified in race and 
income between study-eligible respondent groups that did not complete the survey, which 
provides credence for the validity of online panel samples. Furthermore, survey completers 
overall were similar to the U.S. adult population aged 50 years and older, though somewhat less 
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likely to be married (48% vs. 60%) and to report a household income of $50,000 or higher (43% 
vs. 55%) and more likely to possess a college degree (48% vs. 27%) [15]. The resulting sample 
was also higher in unemployment (59% vs. 47%) compared to nationally representative data 
[16]. These subtle differences in our sample, i.e., lower household income and higher 
unemployment, may in part explain the challenge faced in filling the ≥100k income quota.  
The proportion of females, often overrepresented in research samples, was somewhat higher 
among survey completers in this study (67%) compared to that observed in traditional and other 
online samples within the sample topic area [17-20]. Since other studies have produced more 
balanced gender proportions without implementing quotas, stratification or quota sampling may 
be useful but not necessarily required unless the research dictates an equal gender distribution. 
Another suggestion can be gleaned from the examination of exit points of the study-eligible 
respondent groups that did not complete the survey. That more three-quarters of the non-
completers exited before the survey halfway point and nearly one-half of the quality fail group 
failed the final attention check suggests that participants may have lost interest and paid less 
attention towards the end of the survey. This finding is consistent with best practice guidance to 
keep surveys – whether traditional or online – as short as possible to increase respondent 
retention and attentiveness [21-22]. 
The placement of demographic items is often debated with some recommending that 
demographic items, such as income and age, not be asked at the beginning of a survey [23-24]. 
Within this study, all respondents in the non-completer group provided income and only one 
exited on the age item. Instead, most non-completers exiting within the screening section did so 
while answering health history items. This result suggests that panel samples may be more 
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accustomed to and/or comfortable with answering demographic questions than traditional 
research samples, but may be, nonetheless, sensitive to responding to health-related questions.  
It should also be noted that the median survey duration of the non-completer group was over 
10,000 minutes (data not shown), substantially higher than the median duration of 26 minutes 
among those who completed the survey. Qualtrics panelists have the freedom to “walk away” 
from the survey (e.g. leave survey to answer the door or make dinner). The survey will remain 
open and incomplete until the respondent returns to complete it or the data collection closes to 
the study. Because Qualtrics provides transparency on the total survey duration, researchers may 
consider either excluding responses with excessive duration or removing respondents from the 
survey after a specified period of inactivity.  
Finally, the present study highlights the relative ease of obtaining a racially and 
economically diverse sample via quota sampling and online recruitment methods. This represents 
a major advantage over traditional sampling methods that often consist of predominantly White 
participants [17-19]. Researchers who seek diverse samples should utilize available 
representative samples whenever possible. When access to minorities is limited, however, online 
panel sampling using quotas sampling for race may be a valuable approach for reaching minority 
participants, as demonstrated in this and other panel samples [20, 25]. 
Strengths and Limitations 
This study added transparency to the process of quota sampling and recruiting from an 
online research panel and provided novel information to researchers about how best to 
implement future research using these methods. There are, however, a few important study 
limitations that must be taken into account when interpreting study results. We were unable to 
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characterize panelists who did not interact with the email invitation. Although this was a large 
number of individuals, there are likely a variety of reasons for this such as inactive or busy 
panelists and undeliverable email addresses. Nonetheless, this is an important design factor for 
future studies wishing to use online panels. The present study was also unable to describe 
panelists who did not consent for participation. Additional research is needed to explore 
nonresponse bias in those who do not interact with the survey invitations and decline 
participation. Among those who consented for participation, relatively few sample characteristics 
could be compared across respondent groups. For example, marital status could not be assessed 
across all groups as a result of the order of survey items (e.g., the item assessing marital status 
was at the end of the survey, after many non-completers had exited the survey). Within the 
present study, ineligible and over quota respondents were exited from the survey immediately 
after providing a response that did not meet inclusion criteria or exceeded set quotas. In an effort 
to address non-response bias and incomplete descriptive characteristics, researchers should 
purposely include relevant items (e.g., marital status and education) at the beginning of surveys 
and ask all participants these items, prior to exiting ineligible and over quota respondents from 
the survey. Future research should also extend the present study by examining psychological and 
behavioral characteristics of online survey respondent groups. 
Conclusion 
As the use of online surveys and panel sampling increases, researchers must be cognizant of 
the strengths and potential pitfalls of using online panels and sampling techniques. Online panel 
sampling allows researchers to effectively choose study inclusion criteria and implement quotas 
to obtain racially diverse samples in a shorter period of time than traditional sampling methods. 
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However, researchers must carefully develop quotas to ensure internal and external validity of 
the resulting sample. Although higher numbers of potential participants are contacted in online 
panel sampling, our results suggest that among study-eligible respondents, sociodemographic 
profiles were similar between survey completers and eligible respondents who initiated but did 
not complete the survey. This study produced insights into which sample characteristics 
researchers may want to influence with quota sampling.  
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Figure 1. Diagram of Recruitment and Participation 
 
 
  
  
1,606 Panelists completed consent page 
Did not complete survey (n=138) 
 Failed attention check (n=67) 
 Incomplete response (n=71) 
 
Excluded (n=891) 
 Did not meet inclusion criteria (n=671) 
    − Health history (n=574) 
    − Race (n=73) 
    − Age (n=24) 
 Over quota (n=220) 
 
Declined to participate (n=158) 
 Clicked “I do NOT consent” 
Eligible for participation (n=557) 
 
Consented to participate (n=1,448) 
 Clicked “I consent” 
Completed Survey (n=419) 
 
 
Participation 
Eligibility 
3,178 Panelists interacted with survey 
63,500 Panelists emailed 
Consent 
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Table 1. Respondent Characteristics (n (%)) 
 Eligible Respondents Ineligible Respondents 
 Completers Non-Completers 
 Complete Incomplete Quality Fail Over Quota Ineligible 
Sociodemographic Variables (N=419) (n=71) (n=67) (n=220) (n=671) 
Per Eligibility Criteria      
Mean Age (sd) 58.5 (6.3) 57.1 (5.8) 57.6 (6.4) 61.5 (7.2) 58.7 (8.3) 
   Missing 0 4 (1.0) 0 128 (58.2) 73 (10.9) 
Per Quota Sampling      
Race      
   White 140 (33.4) 14 (19.7) 16 (23.9) 202 (91.8) 235 (35.0) 
   Black 140 (33.4) 37 (52.1) 28 (41.8) 12 (5.5) 185 (27.6) 
   Hispanic 139 (33.2) 17 (23.9) 23 (34.3) 4 (1.8) 178 (26.5) 
   Other n/a n/a n/a n/a 73 (10.9) 
   Missing 0 3 (4.2) 0 2 (0.9) 0 
Income      
   <20k 94 (22.4) 18 (25.4) 25 (37.3) 19 (8.6) no data 
   20-49k 145 (34.6) 21 (29.6) 26 (38.8) 41 (18.6) no data 
   50-74k 90 (21.5) 10 (14.1) 9 (13.4) 18 (8.2) no data 
   75-99k 46 (11.0) 2 (2.8) 3 (4.5) 6 (2.7) no data 
   ≥100k 44 (10.5) 5 (7.0) 4 (6.0) 2 (0.9) no data 
   Missing 0 15 (21.1) 0 134 (60.9) no data 
Natural Probability      
Gender      
   Female 279 (66.6) 51 (71.8) 44 (65.7) 156 (70.9) 440 (65.6) 
   Male 140 (33.4) 17 (23.9) 23 (34.3) 62 (28.2) 231 (34.4) 
   Missing 0 3 (4.2) 0 2 (0.9) 0 
Note. Values may not equal total sample size or 100% due to rounding and missing data.                                                                                                                                                                                                                                                                                    
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Table 2. Survey Completer Characteristics by Race/Ethnic Group (n (%)) 
 Overall White Black Hispanic 
Variable (N=419) (n=71) (n=67) (n=220) 
Sociodemographic     
Mean Age (sd) 58.5 (6.3) 60.1 (6.6) 58.5 (5.9) 57.0 (6.0) 
Female Gender 279 (66.6) 89 (63.6) 95 (67.9) 95 (68.3) 
Currently Marrieda 203 (48.4) 82 (58.6) 48 (34.3) 73 (52.5) 
Income     
   <20k 94 (22.4) 25 (17.9) 36 (25.7) 33 (23.7) 
   20-49k 145 (34.6) 42 (30.0) 57 (40.7) 46 (33.1) 
   50-74k 90 (21.5) 24 (17.1) 33 (23.6) 33 (23.7) 
   75-99k 46 (11.0) 25 (17.9) 8 (5.7) 13 (9.4) 
   ≥100k 44 (10.5) 24 (17.1) 6 (4.3) 14 (10.1) 
College Graduate 203 (48.4) 78 (55.7) 58 (41.4) 67 (48.2) 
Currently Employedb 173 (41.3) 56 (40.0) 52 (37.1) 65 (46.8) 
Insured 368 (87.8) 128 (91.4) 124 (88.6) 116 (83.5) 
English Languagec 400 (95.5) 139 (99.3) 140 (100.0) 121 (87.1) 
Other     
Mean Numeracy (sd)d 1.0 (0.9) 1.3 (1.0) 0.6 (0.8) 1.0 (0.9) 
Mean Health Status (sd)e 3.2 (0.9) 3.3 (1.0) 3.0 (0.8) 3.2 (0.9) 
Mean Health Literacy (sd)f 4.5 (0.8) 4.5 (0.8) 4.6 (0.7) 4.5 (0.7) 
Note. 
a Currently married or living with significant other 
b Currently employed full-time or part-time 
c English is primary language spoken at home 
d Assessed using 3-item scale developed by Schwartz and colleagues [26] 
e Assessed on a 5 point Likert scale, with answers ranging from Poor (1) to Excellent (5) 
f Assessed on a 5 point Likert scale, with answers ranging from Not At All (1) to Extremely (5) 
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Table 3. Study-Eligible Non-Completer Survey Exit Points 
 
Note. Values may not equal total 100% due to rounding.  
Survey Section Item Numbers Respondents Exited (n (%)) 
 
Incomplete Group (n=71) 
Screening 1-10 15 (21.1) 
     Did not start survey 
     Gender 
     Race 
     Age 
     Colon health history 
     Breast health history 
     Income 
      3 (20.0) 
     0 (0.0) 
     0 (0.0) 
     1 (6.7) 
     8 (53.3) 
     3 (20.0) 
     0 (0.0) 
Risk Perceptions and Health 
Behaviors (pre-test) 
11-41 26 (36.6) 
     Did not start section 
     Risk perceptions 
     Health behaviors  
      8 (30.8) 
     13 (50.0) 
     5 (19.2) 
Numeracy 42-48 12 (16.9) 
Lifestyle Behaviors 49-69 4 (5.6) 
Survey Halfway Point 
Risk Assessment Feedback 70-90 2 (2.8) 
Risk Perceptions and  Health 
Behaviors (post-test) 
91-114 11 (15.5) 
Demographics 115-128 1 (1.4) 
Satisfaction 129-133 0 (0.0) 
 
Quality Fail Group (n=67) 
First Attention Item 33 19 (28.4) 
Second Attention Item 64 15 (22.4) 
Third Attention Item 108 33 (49.3) 
  
 
 
 
 104 
References 
1. Dillman, D.A., J.D. Smyth, and L.M. Christian, Internet, phone, mail, and mixed-mode 
surveys: the tailored design method2014: John Wiley & Sons. 
2. Farrell, D. and J.C. Petersen, The growth of internet research methods and the reluctant 
sociologist. Sociological Inquiry, 2010. 80(1): p. 114-125. 
3. Heen, M.S., J.D. Lieberman, and T.D. Miethe, A comparison of different online sampling 
approaches for generating national samples. Center for Crime and Justice Policy, CCJP, 
2014. 1. 
4. Paolacci, G., J. Chandler, and P.G. Ipeirotis, Running experiments on amazon mechanical 
turk. 2010. 
5. Rouse, S.V., A reliability analysis of Mechanical Turk data. Computers in Human 
Behavior, 2015. 43: p. 304-307. 
6. Callegaro, M., et al., Online panel research. Online panel research: A data quality 
perspective, 2014: p. 1-22. 
7. Baker, R., et al., Research Synthesis: AAPOR Report on Online Panels. Public opinion 
quarterly, 2010. 74(4): p. 711-781. 
8. Pew Research Center. Internet/Broadband Fact Sheet. 2018  [cited 2018 2 March]; 
Available from: http://www.pewinternet.org/fact-sheet/internet-broadband/. 
9. Pew Research Center. Mobile Fact Sheet. 2018  [cited 2018 17 May]; Available from: 
http://www.pewinternet.org/fact-sheet/mobile/. 
  
 
 
 
 105 
10. Lugtig, P. and V. Toepoel, The use of PCs, smartphones, and tablets in a probability-
based panel survey: Effects on survey measurement error. Social Science Computer 
Review, 2016. 34(1): p. 78-94. 
11. Göritz, A.S., N. Reinhold, and B. Batinic, Online panels. Online social sciences, 2002: p. 
27-47. 
12. Dunwoody, P.T. and S.G. McFarland, Support for Anti‐Muslim Policies: The Role of 
Political Traits and Threat Perception. Political Psychology, 2018. 39(1): p. 89-106. 
13. Guidry, J.P., et al., Framing and visual type: Effect on future Zika vaccine uptake intent. 
Journal of Public Health Research, 2018. 7(1). 
14. Callegaro, M. and C. DiSogra, Computing response metrics for online panels. Public 
opinion quarterly, 2008. 72(5): p. 1008-1032. 
15. Anderson, G.O. Getting to Know Americans Age 50+. 2014; Available from: 
https://doi.org/10.26419/res.00091.000. 
16. Health Information Nation Trends Survey. HINTS 5, Cycle 1 Data. 2017  [cited 2018 
Mar 4]; Available from: https://hints.cancer.gov/data/Default.aspx. 
17. Lipkus, I.M., et al., Reactions to online colorectal cancer risk estimates among a 
nationally representative sample of adults who have never been screened. Journal of 
behavioral medicine, 2017: p. 1-10. 
18. Molisani, A., Evaluation and Comparison of Theoretical Models' Abilities to Explain and 
Predict Colorectal Cancer Screening Behaviors2015: Virginia Commonwealth 
University. 
  
 
 
 
 106 
19. Ferrer, R.A., et al., An affective booster moderates the effect of gain-and loss-framed 
messages on behavioral intentions for colorectal cancer screening. Journal of behavioral 
medicine, 2012. 35(4): p. 452-461. 
20. Umbach, P.D., Web surveys: Best practices. New directions for institutional research, 
2004. 2004(121): p. 23-38. 
21. Fanning, E., Formatting a paper-based survey questionnaire: Best practices. practical 
assessment research & evaluation, 2005. 10(12): p. 1-14. 
22. Teclaw, R., M.C. Price, and K. Osatuke, Demographic question placement: Effect on 
item response rates and means of a veterans health administration survey. Journal of 
Business and Psychology, 2012. 27(3): p. 281-290. 
23. Pew Research Center. Questionnaire design.  [cited 2018 August 11]; Available from: 
http://www.pewresearch.org/methodology/u-s-survey-research/questionnaire-design/. 
24. Hay, J.L., et al., Deliberative and intuitive risk perceptions as predictors of colorectal 
cancer screening over time. Journal of behavioral medicine, 2016. 39(1): p. 65-74. 
25. Hovick, S.R., et al., User Perceptions and Reactions to an Online Cancer Risk 
Assessment Tool: a Process Evaluation of Cancer Risk Check. Journal of Cancer 
Education, 2017. 32(1): p. 141-147. 
26. Schwartz, L.M., et al., The role of numeracy in understanding the benefit of screening 
mammography. Annals of internal medicine, 1997. 127(11): p. 966-972. 
  
  
 
 
 
 107 
CHAPTER 5 
Conclusion 
Summary 
CRC is the second leading cause of cancer-related mortality in the U.S., accounting for 
approximately 50,000 deaths annually [1]. Although the average lifetime risk of CRC is 
relatively low, the majority of CRC cases occur among those at average risk - with no personal 
or family history of the disease [2]. Therefore, it is imperative that those at average risk perceive 
CRC as a formidable threat and take actions to prevent the disease. The present study was 
conducted to assess whether providing personalized CRC risk assessment feedback including 
behavior change messages would alter risk perceptions and drive risk-reducing behavioral 
intentions among those at average risk and age-eligible for screening.  
Through a series of related papers, this dissertation evaluated the impact of CRC risk 
assessment feedback. The first paper evaluated the effects of providing personalized (vs. generic) 
risk assessment feedback on individuals’ risk perceptions and intentions to engage in three risk-
reducing behaviors. This paper also answered a novel question of whether the provision of CRC 
risk information alters perceptions and intentions of a different cancer, breast cancer, which also 
has strong lifestyle based risks and population based screening programs. The second paper 
examined individuals’ accuracy of perceived lifetime risk of CRC and assessed whether 
improved accuracy was associated with behavior change intentions following risk assessment 
feedback. Finally, the third paper described and evaluated the sampling procedures and survey 
respondent groups of this research. Overall, several significant findings emerged from these three 
papers. 
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Results provided support for the potential role cancer risk assessments may play in 
promoting cancer screening behaviors. That colorectal cancer screening intentions increased 
after receiving risk assessment feedback is particularly remarkable within this average risk 
sample given that: (1) as average risk, having reported no history of CRC, participants were 
provided with a low estimate of lifetime risk (less than 5%); and (2) only half of the sample was 
currently up-to-date according to current screening guidelines and this group can be hard to 
influence as they report more perceived barriers to screening than those who have had a recent 
screening test [2]. Finally, this finding is noteworthy because (3) it suggests that personalized 
risk assessment feedback, which may be more time and resource intensive, was not necessary to 
produce significant increases in screening intentions since changes occurred in both intervention 
arms. 
While improving screening intentions is a positive outcome, it should be emphasized that 
intentions related to diet and physical activity improvement were not similarly impacted. One 
plausible explanation underlying this outcome is that screening may be perceived as a “one and 
done” behavior to reduce CRC risk, while changes in diet and physical activity inherently require 
ongoing lifestyle modification. Common barriers to screening include knowledge gaps and 
structural barriers [3], which can be overcome with narrowly-focused interventions, whereas 
lifestyle changes require more complex interventions, providing support and strategies to 
improve skills and motivation for ongoing change to daily routines and behaviors [4-5]. 
Therefore, it may be that those with lifestyle risk factors would indicate intentions to screening 
simply because it is the “easier” opportunity to mitigate one’s cancer risk.  
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It should also be acknowledged that increased intervention dosage (i.e., repeated exposures 
to messages) is often necessary to increase desired effects [6]. While low intensity interventions, 
such as patient and provider reminders, have produced favorable changes in CRC screening 
behaviors [7-8], the single message “dose” provided in this study may have been insufficient to 
produce changes in intent for the behaviors requiring continuous changes. A systematic review 
of dietary and physical activity interventions supports this suspicion; with results indicating 
effectiveness was associated with increased intervention intensity (e.g., number of sessions, 
frequency of contacts, etc.) and the use of specific behavior change techniques [9]. 
A third possible explanation for the lack of changes in diet and physical activity intentions is 
that the conceptual pathway underlying the expected outcome was not supported. Specifically, it 
was hypothesized that the provision of personalized risk information would increase risk 
perceptions and subsequently, promote higher behavioral changes intentions to mitigate 
heightened perceptions of risk. Instead of producing increased risk perceptions as hypothesized, 
perceived lifetime risk of CRC lowered within both arms. This outcome is not entirely surprising 
given that the sample was comprised of average risk individuals and because people tend to 
regard their own risk optimistically and will reduce perceptions of their own risk to maintain the 
belief that their risk is lower than average [10-11].  
The reduction in perceived lifetime risk reflected improved accuracy following risk 
assessment, a finding consistent with prior studies [12-15]. This dissertation built upon this 
foundation by characterizing who benefited from improved accuracy and assessing if 
improvement in lifetime risk accuracy (at follow up) was associated with changes in behavioral 
intentions. Our findings revealed there was significantly less improvement in accuracy among 
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Blacks and Hispanics (compared to Whites) and individuals with low numeracy. This result 
suggests that different risk communication strategies may be needed for groups who are 
traditionally disadvantaged in the healthcare area. Prior research has shown that interventions are 
more effective when they are culturally appropriate including, for example, language- and 
race/ethnicity-concordant counselors, messages, and materials [17-20]. Therefore, the accuracy 
of minority respondents conceivably could have been improved if the present study provided 
tailored messages based on known cultural factors (e.g., religiosity, racial identity/pride, family 
context) [18-19, 21-22]. This adds to the body of literature promoting cultural relevance in health 
interventions targeting racial/ethnic minorities and extends message tailoring guidance to 
researchers working with diverse samples. Future research should attempt to tease out the 
different pathways underlying differences in risk perception accuracy in different racial/ethnic 
and numeracy groups. 
Although negative outcomes have been linked to inaccurate risk perceptions and accuracy is 
generally regarded as inherently positive [11], the current body of research has not thoroughly 
explored how risk perception accuracy is related to health outcomes [13-16]. We found no 
association between perceived lifetime risk accuracy and behavior change intentions for any of 
the three behavioral outcomes measured. This null result is noteworthy because accuracy was 
achieved through a decrease in perceived risk and thus, conceivably could have had a detrimental 
impact. Within this study in which roughly one quarter of participants reported increased 
intentions to perform risk-reducing behaviors, improved accuracy via a decreased perception of 
risk appears to have neither promoted nor inhibited intentions to adopt health behaviors. These 
results underscore the need for qualitative research to better understand how risk perceptions and 
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behavioral intentions are influenced within the context of risk assessment among those at 
average risk. 
The sample recruited in this research was purposely racially and economically diverse 
because there are known differences in CRC outcomes, screening behaviors, and risk perceptions 
by race and socioeconomic status [23-28]. Since samples acquired through traditional means 
often consist of mostly White participants [29-31], the current study intentionally enrolled over-
represented minority groups in order to garner broad perspectives on cancer risk assessment 
feedback. Future research is planned to examine whether known differences in racial/ethnic 
groups are present within this dataset. However, the sociodemographic characteristics of this 
diverse sample of older adults were compared and several indicators of reasonable sample 
internal validity and external generalizability were found, including limited differences between 
respondent groups and between respondents who completed the survey and the U.S. population 
aged 50 years and older. Taken together, this study provided support for using quota sampling of 
an online panel to acquire a targeted and diverse sample that may have otherwise been difficult 
to recruit in a relatively short period of time. 
Finally, perhaps the most intriguing finding of this dissertation was that risk assessment 
feedback for a specific cancer type produced ‘spillover effects’ on another cancer type. While no 
information was provided related to breast cancer, female participants’ perceived lifetime risk of 
breast cancer lowered and mammography screening intentions increased among those provided 
generic risk information. This finding suggests that generic feedback may be more likely to 
produce spillover effects. Prior research has also indicated that not only is cancer screening 
uptake correlated with the use of other preventative screenings, but that past uptake of either 
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breast or cervical cancer screening directly influences the uptake of screening for the other 
cancer [32]. Furthermore, psychological theory (e.g., cognitive dissonance and the theory of self-
perception) offers potential insights on spillover effects, stating that people tend to think and act 
in consistent ways [33-34]. Therefore, it is conceivable that an intervention that prompts 
increased screening intentions for one cancer type would amplify screening intentions for 
another cancer type, and would similarly produce a consistent impact on cancer risk perceptions. 
Cancer prevention and risk communication professionals should be cognizant of the potentially 
positive or negative public health implications of unintended consequences resulting from risk 
assessment feedback. In order to leverage spillover effects in such a way that intensifies the 
magnitude of cancer prevention efforts, future research is warranted to understand whether and 
under what conditions positive and negative spillover effects occur. Focusing on both CRC and 
breast cancer screening behaviors may be particularly beneficial, as these two cancers combined 
account for nearly 40 percent of all cancers in women [1]. This result, while preliminary, may 
indicate that generic feedback on risk factors (including screening) is more likely to produce 
spillover screening intentions on another cancer screening type. 
Strengths and Limitations 
The primary strength of this dissertation is the focus on an average risk population of adults. 
This group is largely understudied in risk communication research despite being the population 
in which most CRC cases occur. Future research should target this group and aim to uncover 
new ways to promote their interest in adopting risk-reducing lifestyles and behaviors. A second 
strength related to the sample is that it was both racially and economically diverse, a major 
advantage over much of the literature base that is comprised of predominately White sample. 
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However it should be noted that the sample heterogeneity may have played a role in the null 
results observed. As previously mentioned, the present study was potentially limited in that we 
did not address the sample diversity in our personalized messages and because there was 
variation in the personalization of risk messages provided in the treatment arm (depending on 
participant reported engagement in behaviors). Nonetheless, that this dissertation included an 
emphasis on minority participation and focused on nuances of research methods that are 
commonly overlooked in the literature (e.g., quota sampling and recruitment from online 
research panels) represents a strength over other studies. 
Before providing final conclusions, it is important to acknowledge a few limitations of this 
research. The main limitation of this dissertation is that the numeric estimates of lifetime risk 
provided to participants were the average lifetime risk of CRC according to gender in the U.S., 
and as such, were not fully personalized based on each individuals’ reported risk factors. As 
average risk, these estimates would not have change substantially for most. None the less the 
impact of providing person-specific lifetime risk estimates is not known.  
Another chief limitation of this study is related to how accuracy of lifetime risk perception 
was defined. Defined as between four and five percent [35], the range for accuracy was relatively 
narrow. A wider approximate for accuracy (e.g., +/– 5%) may have changed the results and 
implications of this research. In addition, awareness of personal risk factors putting oneself at 
higher than average risk (e.g., eating large amounts of red and process meats or drinking heavily) 
may have influenced respondent reports of lifetime risk and artificially reduced the number of 
participants considered having an accurate perception. It should also be considered that it may 
not be that one’s actual perception of their lifetime risk changed per se as their ability to recall 
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the information changed their response to the question. It was not assessed if participants 
believed the risk estimate information they were given. Further, it is not known if improved 
accuracy remained stable over time. Longitudinal or additional follow-up assessment of accuracy 
is needed to detect changes in accuracy and to examine what, if any, association these changes 
would have with intention for behavior change. 
Another important limitation of this dissertation is that assessment of behaviors was outside 
the scope of the study. While behavioral intentions were used as proxy and previous research 
supports an association between intentions and completed colorectal cancer screening [36-37], it 
should be acknowledged that intentions do not always translate to actual changes in behavior. 
Finally, it was not possible to examine some of the characteristics of different respondent groups 
due to low or missing data. In order to better assess non-response bias, future research should 
ensure that variables of interest are asked to all respondents to the extent possible. 
Conclusion 
Communicating CRC risk information to average risk adults increased CRC-specific 
perceived lifetime risk accuracy and screening intentions. Breast cancer lifetime risk perceptions 
and mammography screening intentions (within the control arm) were also altered among female 
participants. In this study, neither personalized information about risk factors nor improved 
accuracy of lifetime risk were associated with changes in intentions to perform risk reducing 
behaviors, supporting the old adage that knowledge is necessary but not sufficient to drive 
behavior change. Collectively, results support the notion that ‘moving the needle’ in lifestyle 
modification toward CRC prevention is difficult – especially among those with no known family 
history of the disease. Despite the magnitude of the challenges facing cancer prevention 
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researchers, future efforts must continue to develop innovative strategies to prevent CRC as it 
remains a fierce threat that must be addressed. Issues related to the prevention paradox will likely 
persist until better population approaches to cancer risk communication are developed. 
Continued message testing and development is needed related to risk communication, especially 
within minority and low numeracy groups. Future studies could use online survey administration 
and panel sampling, as findings from this research highlighted the ability of these methods to 
produce targeted samples quickly and with reasonable internal validity and external 
generalizability. 
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Start of Block: Consent 
  
 
Q1 RESEARCH PARTICIPANT INFORMATION AND CONSENT FORM 
   
   
 TITLE: Colorectal Risk Assessment among Average Risk Adults 
   
 VCU IRB PROTOCOL NUMBER: HM20009815 
   
 INVESTIGATOR: Maria Thomson, PhD 
                                                                                                  
 If any information contained in this consent form is not clear, please contact the study staff to 
explain any information that you do not fully understand. 
   
 PURPOSE OF THE STUDY 
 The purpose of this research study is to learn more about how people understand and use risk 
information about colorectal cancer that is presented in different ways. You are being asked to 
participate in this study because you are an adult between 50-75 years of age living in the United 
States. 
   
 DESCRIPTION OF THE STUDY AND YOUR INVOLVEMENT 
 This is a survey study. If you decide to be in this research study, you will be asked to click on 
the “agree” button to electronically consent after you have had all your questions answered and 
understand what will happen to you. 
   
 If you agree to participate, you will be randomly assigned to one of two groups. Each group will 
answer the same set of questions related to colorectal cancer and receive risk information that 
will be presented in one of two ways, depending on your group assignment. After viewing the 
risk results, you will be asked to complete a set of follow-up questions. The survey will ask your 
opinions about cancer prevention, your attitudes and beliefs related to colorectal cancer 
specifically, and related preventive health behaviors and intentions, as well as demographic 
questions. The entire survey will take approximately 30 minutes to complete. 
   
  
 
 
 
 122 
 RISKS AND DISCOMFORTS 
 There are no physical risks associated with this study. We do not foresee any significant risks or 
discomfort to your participation. However, it is possible that some questions could be distressing 
to some people, such as questions relating to their personal and family history of cancer. In 
addition, participants will receive a numeric risk indicator, which some participants may find 
upsetting. 
   
 If you choose to participate in this study, please keep in mind that if you do become 
uncomfortable and do not wish to answer the survey questions, you may stop at any time by 
exiting the survey. 
   
 BENEFITS TO YOU AND OTHERS 
 You may not receive any direct benefits by participating in this research, but you may get the 
opportunity and satisfaction of learning more about and contributing to research in this field. 
   
 COSTS 
 There are no costs for participating in this study other than the time you will spend filling out 
the online survey. 
   
 PAYMENT FOR PARTICIPATION 
 Survey respondents will receive compensation for participation. You will receive the agreed 
upon incentive provided by Qualtrics after completing the survey. There will be no payment for 
incomplete surveys, meaning you will not receive compensation if you choose to exit the study 
prior to completing the survey in its entirety. 
   
 ALTERNATIVES 
 The alternative to participating in this study is to not participate. 
   
 CONFIDENTIALITY 
 The surveys will be administered online via Qualtrics. Data collected in the survey is completely 
anonymous, meaning that there is no way to connect your identity to your responses. Survey data 
will be maintained on a HIPAA secured computer and drive; no identifying information or keys 
will be included. The results of this study may be used in reports, presentations, or publications, 
but your name will not be used. 
   
 VOLUNTARY PARTICIPATION AND WITHDRAWAL 
 Your participation is voluntary. You may decide not to participate in this study. Your decision 
not to take part will involve no penalty or loss of benefits to which you are otherwise entitled.   
   
 If you choose to participate, you may stop at any time without any penalty. However, 
participation involves answering all survey questions, including potentially sensitive questions 
(i.e., questions related to their personal and family history of cancer). Thus, you will not receive 
compensation if you choose to exit the study prior to completing the survey in its entirety. 
   
  
 
 
 
 123 
 QUESTIONS 
 If you have any questions, complaints, or concerns about your participation in this research, 
contact the Principal Investigator: 
   
 Maria Thomson, PhD at Maria.Thomson@vcuhealth.org. 
   
 The researcher named above is the best person to contact for questions about your participation 
in this study. 
   
 If you have any general questions about your rights as a participant in this or any other research, 
you may contact: 
   
 Office of Research 
 Virginia Commonwealth University 
 800 East Leigh Street, Suite 3000 
 P.O. Box 980568 
 Richmond, VA 23298 
 Telephone: (804) 827-2157 
   
 Contact this number for general questions, concerns or complaints about research. You may also 
call this number if you cannot reach the research team or if you wish to talk with someone else. 
General information about participation in research studies can also be found at 
http://www.research.vcu.edu/irb/volunteers.htm. 
   CONSENT I have been provided with an opportunity to read this consent form carefully. 
   
 By clicking the “I consent” button, I have not waived any of the legal rights or benefits, to 
which I otherwise would be entitled. My clicking indicates that I freely consent to participate in 
this research study.  
o I consent  (1)  
o I do NOT consent  (0)  
 
Skip To: End of Block If RESEARCH PARTICIPANT INFORMATION AND CONSENT FORM    TITLE: Colorectal Risk 
Assessment among Aver... = I do NOT consent 
End of Block: Consent 
 
Start of Block: Screening Qs 
 
Q2 Welcome! The following survey is about your attitudes and behaviors related to colorectal 
cancer. Colorectal cancer is cancer of the colon (large bowel, large intestine) or rectum.     Please 
answer each question to the best of your ability. Remember, these questions are about your 
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attitudes and behaviors; there are no “right” or “wrong” answers to these questions.      Thank 
you for taking the time to complete this survey. 
 
 
Page Break  
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Q3 Are you male or female? 
o Male  (1)  
o Female  (0)  
 
 
  
 
Q4 Which of the following categories best describes you? 
o White  (1)  
o Black or African American  (2)  
o Hispanic, Latino, or Spanish origin  (3)  
o Some other race, ethnicity, or origin  (4)  
 
Skip To: End of Block If Which of the following categories best describes you? = Some other race, ethnicity, or origin 
 
 
 
Q5 What is your age (in years)? 
________________________________________________________________ 
 
Skip To: End of Block If What is your age (in years)? <= 49 
Skip To: End of Block If What is your age (in years)? >= 76 
 
Page Break  
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Q6 Have you ever been told by a doctor or other healthcare provider that you have polyps in 
your colon or rectum? Polyps are small growths that are not cancerous but are often removed to 
prevent cancer from developing.  
o Yes  (1)  
o No  (0)  
 
Skip To: End of Block If Have you ever been told by a doctor or other healthcare provider that you have polyps in 
your col... != No 
 
  
 
Q7 Have you ever been told by a doctor or other healthcare provider that you have colon cancer 
(cancer of the large bowel, large intestine, or rectum?  
o Yes  (1)  
o No  (0)  
 
Skip To: End of Block If Have you ever been told by a doctor or other healthcare provider that you have colon cancer 
(canc... != No 
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Q8 Please indicate if any of the following statements are true for you: 
  
I have a history of inflammatory bowel disease 
(e.g. ulcerative colitis or Crohn’s disease). 
(Q8_1)  
▼    Yes   (1) ...   No   (2) 
At least one of my parents, siblings, or 
children has been told they have polyps or 
colorectal cancer. (Q8_2)  
▼    Yes   (1) ...   No   (2) 
I have a known family history of a hereditary 
colorectal cancer syndrome such as familial 
adenomatous polyposis (FAP) or hereditary 
nonpolyposis colon cancer (HNPCC), also 
known as Lynch Syndrome. (Q8_3)  
▼    Yes   (1) ...   No   (2) 
 
 
Skip To: End of Block If Please indicate if any of the following statements are true for you: != At least one of my 
parents, siblings, or children has been told they have polyps or colorectal cancer. 
Skip To: End of Block If Please indicate if any of the following statements are true for you: != At least one of my 
parents, siblings, or children has been told they have polyps or colorectal cancer. 
Skip To: End of Block If Please indicate if any of the following statements are true for you: != At least one of my 
parents, siblings, or children has been told they have polyps or colorectal cancer. 
 
Display This Question: 
If Are you male or female? = Female 
  
 
Q9 Please indicate if any of the following statements are true for you: 
  
I have at least one first-degree relative (e.g., 
mother, sisters, or daughters) who has been 
told they have breast cancer. (Q9_1)  
▼    Yes   (1) ...   No   (2) 
I have a known or suspected mutation in either 
the BRCA1 or BRCA2 gene or an inherited 
cancer-causing syndrome, such as the Li-
Fraumeni syndrome. (Q9_2)  
▼    Yes   (1) ...   No   (2) 
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Q10 Which of the following ranges best describes your household's total income (before taxes) 
in the previous year? 
o Less than $20,000  (1)  
o $20,000 to $49,999  (2)  
o $50,000 to $74,999  (3)  
o $75,000 to $99,999  (4)  
o $100,000 or more  (5)  
 
 
Page Break  
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End of Block: Screening Qs 
 
Start of Block: PRE-RP Group 1 
 
 
Q11  
YOU AND COLON CANCER   
    
  On a scale from 0 to 100 %, how would you rate the probability that you will develop colorectal 
cancer in the future?  
________________________________________________________________ 
 
 
  
 
Q12       
 
Very unlikely 
(1) 
Unlikely (2) 
Neither likely 
nor unlikely 
(3) 
Likely (4) 
Very likely 
(5) 
How likely is 
it that you 
will get 
colorectal 
cancer at 
some point in 
the future? 
(Q12)  
o  o  o  o  o  
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Q13       
 
Much lower 
(1) 
A little lower 
(2) 
The same (3) 
A little higher 
(4) 
Much higher 
(5) 
How do you 
think your 
chance of 
developing 
colorectal 
cancer in the 
future 
compares to 
the average 
person of 
your gender 
and age? 
(Q13)  
o  o  o  o  o  
 
 
 
  
 
Q14       
 Very low (1) Low (2) 
Neither low 
nor high (3) 
High (4) Very High (5) 
The way I 
look after my 
health means 
that my odds 
of getting 
colorectal 
cancer in the 
future are: 
(Q14)  
o  o  o  o  o  
 
 
End of Block: PRE-RP Group 1 
 
Start of Block: PRE-RP Group 2 
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Q15     
 Not at all (1) A little (2) 
A moderate 
amount (3) 
A lot (4) Extremely (5) 
How worried 
are you about 
developing 
colorectal 
cancer in the 
future? 
(Q15_1)  
o  o  o  o  o  
How fearful 
are you about 
developing 
colorectal 
cancer in the 
future? 
(Q15_2)  
o  o  o  o  o  
How nervous 
are you about 
developing 
colorectal 
cancer in 
your lifetime? 
(Q15_3)  
o  o  o  o  o  
How 
concerned 
are you about 
developing 
colorectal 
cancer in 
your lifetime? 
(Q15_4)  
o  o  o  o  o  
How easy is 
it for you to 
imagine 
yourself 
developing 
colorectal 
cancer in the 
future? 
(Q15_5)  
o  o  o  o  o  
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When you 
think about 
colorectal 
cancer for a 
moment, to 
what extent 
do you feel 
fearful? 
(Q15_6)  
o  o  o  o  o  
When you 
think about 
colorectal 
cancer for a 
moment, to 
what extent 
do you feel 
worried? 
(Q15_7)  
o  o  o  o  o  
When you 
think about 
colorectal 
cancer for a 
moment, to 
what extent 
do you feel 
anxious? 
(Q15_8)  
o  o  o  o  o  
 
 
End of Block: PRE-RP Group 2 
 
Start of Block: PRE-RP Group 3 
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Q16     
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
When I think 
carefully 
about my 
lifestyle it 
does seem 
possible that I 
could get 
colorectal 
cancer. 
(Q16_1)  
o  o  o  o  o  
If I look at 
myself as if I 
were a doctor, 
I realize that 
my behavior 
puts me at 
risk of getting 
cancer. 
(Q16_2)  
o  o  o  o  o  
I feel very 
vulnerable to 
colorectal 
cancer. 
(Q16_3)  
o  o  o  o  o  
I am 
confident that 
I will not get 
colorectal 
cancer. 
(Q16_4)  
o  o  o  o  o  
I would be 
lying if I said 
“There is no 
chance of me 
getting 
colorectal 
cancer.” 
o  o  o  o  o  
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(Q16_5)  
My first 
reaction when 
I hear of 
someone 
getting 
colorectal 
cancer is 
“that could be 
me 
someday.” 
(Q16_6)  
o  o  o  o  o  
 
 
End of Block: PRE-RP Group 3 
 
Start of Block: PRE-BCA RP 
 
 
Q17  
YOU AND BREAST CANCER   
    
  On a scale from 0 to 100 %, how would you rate the probability that you will develop BREAST 
cancer in the future?  
________________________________________________________________ 
 
 
  
 
  
 
 
 
 135 
Q18       
 
Very unlikely 
(1) 
Unlikely (2) 
Neither likely 
nor unlikely 
(3) 
Likely (4) 
Very likely 
(5) 
How likely is 
it that you 
will get 
BREAST 
cancer at 
some point in 
the future? 
(Q18)  
o  o  o  o  o  
 
 
 
  
 
Q19       
 
Much lower 
(1) 
A little lower 
(2) 
The same (3) 
A little higher 
(4) 
Much higher 
(5) 
How do you 
think your 
chance of 
developing 
BREAST 
cancer in the 
future 
compares to 
the average 
person of 
your gender 
and age? 
(Q19)  
o  o  o  o  o  
 
 
End of Block: PRE-BCA RP 
 
Start of Block: PRE-DEM RP 
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Q20  
YOU AND DEMENTIA   
    
  On a scale from 0 to 100 %, how would you rate the probability that you will develop 
DEMENTIA in the future?  
________________________________________________________________ 
 
 
  
 
Q21       
 
Very unlikely 
(1) 
Unlikely (2) 
Neither likely 
nor unlikely 
(3) 
Likely (4) 
Very likely 
(5) 
How likely is 
it that you 
will get 
DEMENTIA 
at some point 
in the future? 
(Q21)  
o  o  o  o  o  
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Q22       
 
Much lower 
(1) 
A little lower 
(2) 
The same (3) 
A little higher 
(4) 
Much higher 
(5) 
How do you 
think your 
chance of 
developing 
DEMENTIA 
in the future 
compares to 
the average 
person of 
your gender 
and age? 
(Q22)  
o  o  o  o  o  
 
 
End of Block: PRE-DEM RP 
 
Start of Block: Screening HX 
 
Q23  
CANCER SCREENING TESTS 
    
The next few questions are about some different tests you may have already had to look for 
signs of cancer. 
 
 
Display This Question: 
If Are you male or female? = Female 
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Q24  
  
A MAMMOGRAM is an x-ray picture of the breast.   
  Have you ever had a mammogram? 
o Yes  (1)  
o No  (0)  
o I Don't Know  (9)  
 
 
Display This Question: 
If A MAMMOGRAM is an x-ray picture of the breast.  Have you ever had a mammogram? = Yes 
  
 
Q25 When was your most recent mammogram? 
o 2 years ago or less  (1)  
o More than 2 years ago  (2)  
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Q26  
  
FECAL OCCULT BLOOD TEST (FOBT)    
  
    
A FOBT IS DONE AT HOME to determine whether your stool contains blood. You take small 
samples of your fecal matter or stool and return the sample to be tested.  
    
Have you ever had one of these stool blood tests?  
o Yes  (1)  
o No  (0)  
o I Don't Know  (9)  
 
 
Display This Question: 
If FECAL OCCULT BLOOD TEST (FOBT)   A FOBT IS DONE AT HOME to determine whether your stool contains... = 
Yes 
  
 
Q27 When was your most recent FOBT? 
o 1 year ago or less  (1)  
o More than 1 year ago  (2)  
 
 
Page Break  
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Q28  
The next two questions are about sigmoidoscopy and colonoscopy. Both tests examine the 
colon using a narrow, lighted tube that is inserted in the rectum. 
 
 
  
 
Q29  
  
SIGMOIDOSCOPY    
    A sigmoidoscopy (pronounced: sig-MOY-DAHS-kuh-pee) is also referred to as flexible 
sigmoidoscopy or “flex sig.” Sigmoidoscopy examines only the lower part of the colon. You are 
awake during the test, can drive yourself home, and can resume normal activities after the 
test.    Have you ever had a sigmoidoscopy?   
o Yes  (1)  
o No  (0)  
o I Don't Know  (9)  
 
 
Display This Question: 
If SIGMOIDOSCOPY   A sigmoidoscopy (pronounced: sig-MOY-DAHS-kuh-pee) is also referred to as flexibl... = 
Yes 
  
 
Q30 When was your most recent sigmoidoscopy? 
o 1 year ago or less  (1)  
o More than 1 but not more than 5 years ago  (2)  
o More than 5 but not more than 10 years ago  (3)  
o More than 10 years ago  (4)  
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Q31  
  
COLONOSCOPY    
  
    
A colonoscopy (pronounced: koh-luh-NAHS-kuh-pee) is a test that uses a narrow, lighted tube to 
examine the entire colon. With a colonoscopy, you are sleepy or asleep during the test, need 
someone to drive you home, and need to take the rest of the day off from normal activities.  
    
Have you ever had a colonoscopy?  
o Yes  (1)  
o No  (0)  
o I Don't Know  (9)  
 
 
Display This Question: 
If COLONOSCOPY   A colonoscopy (pronounced: koh-luh-NAHS-kuh-pee) is a test that uses a narrow, ligh... = 
Yes 
  
 
Q32 When was your most recent colonoscopy? 
o 1 year ago or less  (1)  
o More than 1 but not more than 5 years ago  (2)  
o More than 5 but not more than 10 years ago  (3)  
o More than 10 years ago  (4)  
 
 
  
 
  
 
 
 
 142 
Q33 To make sure you are paying attention, please answer yes for this question. 
o Yes  (1)  
o No  (0)  
o I Don't Know  (9)  
 
Skip To: End of Block If To make sure you are paying attention, please answer yes for this question. != Yes 
End of Block: Screening HX 
 
Start of Block: PRE-BI 
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Q34  
HEALTH BEHAVIORS 
 Not at all (1) A little (2) 
A moderate 
amount (3) 
A lot (4) Extremely (5) 
CRCS UTD != 1 
How likely 
are you to get 
tested for 
colorectal 
cancer in the 
next 6 
months? 
(Q34_1)  
o  o  o  o  o  
CRCS UTD = 1 
How likely 
are you to get 
tested for 
colorectal 
cancer (when 
you are due 
to be tested 
again)? 
(Q34_2)  
o  o  o  o  o  
Are you male or 
female? = 
Female 
And Mammo 
UTD != 1 
How likely 
are you to get 
a 
mammogram 
in the next 6 
months? 
(Q34_3)  
o  o  o  o  o  
Are you male or 
female? = 
Female 
And Mammo 
o  o  o  o  o  
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UTD = 1 
How likely 
are you to get 
a 
mammogram 
(when you 
are due to get 
a 
mammogram 
again)? 
(Q34_4)  
How likely 
are you to 
improve your 
diet in the 
next 6 
months? 
(Q34_5)  
o  o  o  o  o  
How likely 
are you to 
increase your 
physical 
activity in the 
next 6 
months? 
(Q34_6)  
o  o  o  o  o  
How likely 
are you to 
talk to a 
doctor about 
getting tested 
for colorectal 
cancer in the 
next 6 
months? 
(Q34_7)  
o  o  o  o  o  
 
 
 
Page Break  
  
  
 
 
 
 145 
  
 
Q35 Do you have a healthy diet? 
o YES, I have a healthy diet and I have for MORE than 6 months. (1)  
o YES, I have a healthy diet and I have for LESS than 6 months. (2)  
o NO, but I intend to improve my diet in the next 30 days. (3)  
o NO, but I intend to improve my diet in the next 6 months. (4)  
o NO, and I do NOT intend to improve my diet in the next 6 months. (5)  
 
 
  
 
Q36 Are you physically active? 
o YES, I am physically active and I have been for MORE than 6 months. (1)  
o YES, I am physically active and I have been for LESS than 6 months. (2)  
o NO, but I intend to increase my physical activity in the next 30 days. (3)  
o NO, but I intend to increase my physical activity in the next 6 months. (4)  
o NO, and I do NOT intend to increase my physical activity in the next 6 months. (5)  
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Q37 Do you screen for colorectal cancer regularly (as recommended by your healthcare 
provider)? 
o YES, I screen for colorectal cancer regularly, AND I intend to get screened for colorectal 
cancer when I am due again. (1)  
o YES, I screen for colorectal cancer regularly, BUT I do NOT intend to get screened for 
colorectal cancer when I am due again. (2)  
o NO, but I intend to get screened for colorectal cancer in the next 30 days. (3)  
o NO, but I intend to get screened for colorectal cancer in the next 6 months. (4)  
o NO, and I do NOT intend to get screened for colorectal cancer in the next 6 months. (5)  
 
 
Display This Question: 
If Are you male or female? = Female 
  
 
Q38 Do you screen for breast cancer regularly (as recommended by your healthcare provider)? 
o YES, I screen for breast cancer regularly, AND I intend to get screened for breast cancer 
when I am due again. (1)  
o YES, I screen for breast cancer regularly, BUT I do NOT intend to get screened for breast 
cancer when I am due again. (2)  
o NO, but I intend to get screened for breast cancer in the next 30 days. (3)  
o NO, but I intend to get screened for breast cancer in the next 6 months. (4)  
o NO, and I do NOT intend to get screened for breast cancer in the next 6 months. (5)  
 
End of Block: PRE-BI 
 
Start of Block: Self-Efficacy 
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Q39  
ATTITUDES AND BELIEFS 
   
 
Very difficult 
(1) 
Difficult (2) 
Neither easy 
nor difficult 
(3) 
Easy (4) Very easy (5) 
For me, 
improving 
my diet in 
the next 6 
months 
would be: 
(Q39_1)  
o  o  o  o  o  
For me, 
increasing 
my physical 
activity in the 
next 6 months 
would be: 
(Q39_2)  
o  o  o  o  o  
For me, 
getting 
tested for 
colorectal 
cancer in the 
next 6 months 
would be: 
(Q39_3)  
o  o  o  o  o  
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Q40       
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
If I wanted to, 
I could easily 
improve my 
diet in the 
next 6 
months. 
(Q40_1)  
o  o  o  o  o  
If I wanted to, 
I could easily 
increase my 
physical 
activity in the 
next 6 
months. 
(Q40_2)  
o  o  o  o  o  
If I wanted to, 
I could easily 
get tested for 
colorectal 
cancer in the 
next 6 
months. 
(Q40_3)  
o  o  o  o  o  
 
 
End of Block: Self-Efficacy 
 
Start of Block: PRE-Beliefs/AVOID, and NUM 
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Q41 How much do you agree or disagree with each of the following statements?    
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
Cancer is most 
often caused by a 
person's behavior 
or lifestyle. 
(Q41_1)  
o  o  o  o  o  
It seems like 
everything 
causes cancer. 
(Q41_2)  
o  o  o  o  o  
There's not much 
you can do to 
lower your 
chances of 
getting cancer. 
(Q41_3)  
o  o  o  o  o  
There are so 
many different 
recommendations 
about preventing 
cancer, it's hard 
to know which 
ones to follow. 
(Q41_4)  
o  o  o  o  o  
I'd rather not 
know my chance 
of getting cancer. 
(Q41_5)  
o  o  o  o  o  
 
 
 
Page Break  
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Q42  
CHANCE AND PROBABILITIES 
   
  
 
 
 
Q43  
Please answer the following questions to the best of your ability and give your responses in 
NUMBERS ONLY - no words or symbols (i.e., 12, not "twelve").  
 
 
   
 
Q44 Imagine that we rolled a fair, six-sided die 1,000 times. Out of 1,000 rolls, how many times 
do you think the die would come up even (2, 4, or 6)? 
 _______ out of 1,000 (1) 
 
 
   
 
Q45 In the BIG BUCKS LOTTERY, the chance of winning a $10 prize is 1%. What is your best 
guess about how many people would win a $10 prize if 1,000 people each buy a single ticket to 
BIG BUCKS? 
 _______ people out of 1,000 (1) 
 
 
   
 
Q46 In the ACME PUBLISHING SWEEPSTAKES, the chance of winning a car is 1 in 1,000. 
What percent of tickets to ACME PUBLISHING SWEEPSTAKES win a car? 
 _______ % (1) 
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Q47 If the chance of getting a disease is 10%, how many people would be expected to get the 
disease: 
o Out of 100?  (2) ________________________________________________ 
o Out of 1,000?  (3) ________________________________________________ 
 
 
 
Q48 Timing 
First Click  (1) 
Last Click  (2) 
Page Submit  (3) 
Click Count  (4) 
 
 
Page Break  
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End of Block: PRE-Beliefs/AVOID, and NUM 
 
Start of Block: CCRAT Items 
 
 
Q49  
ABOUT YOU    
    
  What is your height without shoes? 
o Feet  (1) ________________________________________________ 
o Inches  (2) ________________________________________________ 
 
 
 
 
Q50  
What is your weight without shoes? 
o Pounds (lbs)  (1) ________________________________________________ 
 
 
 
 
Q51 A drink of alcohol is 1 can or bottle of beer, 1 glass of wine, 1 can or bottle of wine cooler, 
1 cocktail, or 1 shot of liquor.  
    
On average, how many days per week do you have at least one drink of any alcoholic beverage? 
________________________________________________________________ 
 
 
Display This Question: 
If If A drink of alcohol is 1 can or bottle of beer, 1 glass of wine, 1 can or bottle of wine cooler, 1 cocktail, or 1 
shot of liquor.&nbsp; &nbsp;  During the past 30 days, how many days per week did yo... Text Response Is Not 
Equal to  0 
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Q52 On days when you drink, about how many drinks do you have on the average? 
________________________________________________________________ 
 
 
Page Break  
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Q53 In your entire lifetime, altogether, have you smoked 100 or more cigarettes? 
o Yes  (1)  
o No  (0)  
o I don't know  (9)  
 
 
Display This Question: 
If In your entire lifetime, altogether, have you smoked 100 or more cigarettes? = Yes 
 
Q54 How old were you when you started smoking cigarettes on a regular basis, that is, at least 
one cigarette a day for six months or longer? 
▼ I have never smoked cigarettes regularly. (1) ... 54 (50) 
 
 
Display This Question: 
If How old were you when you started smoking cigarettes on a regular basis, that is, at least one ci... , I have 
never smoked cigarettes regularly. Is Displayed 
And How old were you when you started smoking cigarettes on a regular basis, that is, at least one ci... != I 
have never smoked cigarettes regularly. 
  
 
Q55 Do you currently smoke cigarettes? 
o Yes  (1)  
o No  (0)  
 
 
Display This Question: 
If Do you currently smoke cigarettes? = No 
 
Q56 How old were you when you quit smoking cigarettes completely?  
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NOTE: If you quit smoking cigarettes completely more than one time, please tell us how old you 
were the last time you quit smoking completely.  
  
  
    
▼ 16 (1) ... 54 (39) 
 
 
Display This Question: 
If How old were you when you started smoking cigarettes on a regular basis, that is, at least one ci... , I have 
never smoked cigarettes regularly. Is Displayed 
And How old were you when you started smoking cigarettes on a regular basis, that is, at least one ci... != I 
have never smoked cigarettes regularly. 
  
 
Q57 Thinking back over the years you have smoked regularly, about how many cigarettes have 
you usually smoked a day? 
o 1 to 10 cigarettes a day  (1)  
o 11 to 20 cigarettes a day  (2)  
o More than 20 cigarettes a day  (3)  
 
 
Page Break  
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Q58  
  
Vegetables INCLUDE raw, cooked, canned, and frozen vegetables (including beans) and leafy 
green salads. DO NOT INCLUDE fried vegetables like French fries or fried potatoes.   
    
  In the past 30 days, about how many servings per week of vegetables or leafy green salads did 
you eat? 
o None  (1)  
o Less than 1 serving per week  (2)  
o 1-2 servings per week  (3)  
o 3-4 servings per week  (4)  
o 5-6 servings per week  (5)  
o 7-10 servings per week  (6)  
o More than 10 servings per week  (7)  
 
 
Display This Question: 
If Vegetables INCLUDE raw, cooked, canned, and frozen vegetables (including beans) and leafy green s... != 
None 
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Q59 In the past 30 days, how much did you usually eat in each serving of vegetables or leafy 
green salads? 
o 1/2 cup or less  (1)  
o Between 1/2 cup and 1 1/2 cups  (2)  
o Between 1 1/2 cups and 3 cups  (3)  
o Between 3 cups and 5 cups  (4)  
o More than 5 cups  (5)  
 
 
Page Break  
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Q60  
Moderate physical activities DO NOT cause you to sweat or breathe hard. Some examples 
include vacuuming, gardening, easy walking for exercise, and so on. 
 
 
 
 
In a typical week, how many days, if any, did you do any kind of moderate physical activity? 
________________________________________________________________ 
 
 
Display This Question: 
If If Moderate physical activities DO NOT cause you to sweat or breathe hard. Some examples include va... Text 
Response Is Not Equal to  0 
 
 
Q61 During those days, on average, about how many minutes per day did you do moderate 
physical activities? 
________________________________________________________________ 
 
 
Page Break  
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Q62  
 
Vigorous activities include all activities that DO cause you to sweat or breathe hard. Some 
examples include racquet sports, basketball, running, fast biking, exercise class, weight 
lifting, backpacking, swimming, and heavy labor such as shoveling dirt. 
 
 
 
 
In a typical week, how many days, if any, did you do any kind of vigorous physical activity? 
________________________________________________________________ 
 
 
Display This Question: 
If If Vigorous activities include all activities that DO cause you to sweat or breathe hard. Some exam... Text 
Response Is Not Equal to  0 
 
 
Q63 During those days, on average, about how many minutes per day did you do 
vigorous physical activities? 
________________________________________________________________ 
 
 
Page Break  
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Q64 To confirm that your responses in the survey are valid, please select disagree for this 
question. 
o Strongly agree  (4)  
o Agree  (5)  
o Somewhat agree  (6)  
o Neither agree nor disagree  (7)  
o Somewhat disagree  (8)  
o Disagree  (9)  
o Strongly disagree  (10)  
 
Skip To: End of Block If To confirm that your responses in the survey are valid, please select disagree for this 
question. != Disagree 
 
Page Break  
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Q65  
During the past 30 days, have you taken medications containing aspirin at least 3 times a week, 
such as:    
   - Bufferin    
   - Bayer    
   - Excedrin    
   - Other generic form    
NOTE: Do NOT include TYLENOL 
o Yes  (1)  
o No  (0)  
o I Don't Know  (9)  
 
 
  
 
Q66  
During the past 30 days, have you taken medications that do NOT contain aspirin at least 3 
times a week, such as:   
   - Advil    
   - Aleve    
   - Celebrex    
   - Ibuprofen    
   - Motrin    
   - Naproxen    
   - Nuprin    
NOTE: Do NOT include TYLENOL 
o Yes  (1)  
o No  (0)  
o I Don't Know  (9)  
 
 
Page Break  
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Display This Question: 
If Are you male or female? = Female 
 
 
Q67 Do you still have periods? 
o Yes  (1)  
o No  (0)  
 
 
Display This Question: 
If Do you still have periods? = No 
 
Q68  
When did you have your last period? 
 
 
o 1 year ago or less  (1)  
o More than 1 year ago but less than 2 years ago  (2)  
o 2 years ago or more  (3)  
 
 
Display This Question: 
If When did you have your last period? = 2 years ago or more 
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Q69  
During the past 2 years, have you used estrogen, progestin, or other female hormones? 
  
These hormones may be given as hormone pills, oral contraceptives, shots, skin patches, vaginal 
creams, or as vaginal suppositories. 
o Yes  (1)  
o No  (0)  
 
 
Page Break  
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End of Block: CCRAT Items 
 
Start of Block: MEN - INT MSG 
 
Q70  
Your Colorectal Cancer Risk Summary   
  
    
*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***   
    
 
    
 
 Estimates are not exact. Your risk for developing colorectal cancer during your lifetime may be 
higher or lower.  
 
 
 
Q71 Timing 
First Click  (1) 
Last Click  (2) 
Page Submit  (3) 
Click Count  (4) 
 
 
Page Break  
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Q72  
  
Your Colorectal Cancer Risk Summary   
  
    
*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***     
 
     
  
Although average risk for colorectal cancer is only about 5%, this is just an estimate. An 
individual's risk of developing cancer can be affected by lifestyle choices. The personalized 
health messages below are based on your answers to this survey:    
 
[Men Intervention Message]     
 
 
  
 
Q73   
 
Not at all 
carefully (1) 
Slightly 
carefully (2) 
Somewhat 
carefully (3) 
Moderately 
carefully (4) 
Very 
carefully (5) 
To what 
extent did 
you carefully 
review the 
information 
on this page? 
(Q73_1)  
o  o  o  o  o  
 
 
 
 
Q74 Timing 
First Click  (1) 
Last Click  (2) 
Page Submit  (3) 
Click Count  (4) 
 
End of Block: MEN - INT MSG 
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Start of Block: MEN - CON MSG 
 
Q75  
Your Colorectal Cancer Risk Summary   
  
    
*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***   
    
 
    
 
 Estimates are not exact. Your risk for developing colorectal cancer during your lifetime may be 
higher or lower.  
 
 
 
Q76 Timing 
First Click  (1) 
Last Click  (2) 
Page Submit  (3) 
Click Count  (4) 
 
 
Page Break  
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Q77  
  
Your Colorectal Cancer Risk Summary   
  
    
*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***     
 
     
Although the average lifetime risk for colorectal cancer is only about 5%, this is just an 
estimate. An individual's risk of developing cancer can be affected by lifestyle choices. 
     
Factors that can make your risk of colorectal cancer higher include:    Close relatives 
(parents, brothers, sisters, or children) who have had colorectal cancer  History of colorectal 
polyps  Obesity  Cigarette smoking  Inactive lifestyle    
    
Factors that can lower your risk of colorectal cancer include:    Colorectal cancer screening 
 Regular use of aspirin and NSAID’s  Maintaining a healthy weight Regular, vigorous 
exercise (all activities that cause sweating and heavy breathing)  A diet high in vegetables 
 Hormone replacement therapy use in women  
 
 
 
Q78   
 
Not at all 
carefully (1) 
Slightly 
carefully (2) 
Somewhat 
carefully (3) 
Moderately 
carefully (4) 
Very 
carefully (5) 
To what 
extent did 
you carefully 
review the 
information 
on this page? 
(1)  
o  o  o  o  o  
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Q79 Timing 
First Click  (1) 
Last Click  (2) 
Page Submit  (3) 
Click Count  (4) 
 
End of Block: MEN - CON MSG 
 
Start of Block: WOMEN - INT MSG 
 
Q80  
Your Colorectal Cancer Risk Summary   
  
    
*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***   
 
     
   
    
Estimates are not exact. Your risk for developing colorectal cancer during your lifetime may be 
higher or lower.  
 
 
 
Q81 Timing 
First Click  (1) 
Last Click  (2) 
Page Submit  (3) 
Click Count  (4) 
 
 
Page Break  
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Q82  
  
Your Colorectal Cancer Risk Summary   
  
    
*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***     
 
     
  
Although average risk for colorectal cancer is only about 5%, this is just an estimate. An 
individual's risk of developing cancer can be affected by lifestyle choices. The personalized 
health messages below are based on your answers to this survey:  
      
[Women Intervention Message]     
 
 
 
Q83   
 
Not at all 
carefully (1) 
Slightly 
carefully (2) 
Somewhat 
carefully (3) 
Moderately 
carefully (4) 
Very 
carefully (5) 
To what 
extent did 
you carefully 
review the 
information 
on this page? 
(1)  
o  o  o  o  o  
 
 
 
 
Q84 Timing 
First Click  (1) 
Last Click  (2) 
Page Submit  (3) 
Click Count  (4) 
 
End of Block: WOMEN - INT MSG 
 
Start of Block: WOMEN - CON MSG 
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Q85  
Your Colorectal Cancer Risk Summary   
  
    
*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***   
 
     
   
    
Estimates are not exact. Your risk for developing colorectal cancer during your lifetime may be 
higher or lower.  
 
 
 
Q86 Timing 
First Click  (1) 
Last Click  (2) 
Page Submit  (3) 
Click Count  (4) 
 
 
Page Break  
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Q87  
  
Your Colorectal Cancer Risk Summary   
  
    
*** PLEASE REVIEW THE FOLLOWING INFORMATION CAREFULLY ***     
    
    
Although the average lifetime risk for colorectal cancer is only about 5%, this is just an 
estimate. An individual's risk of developing cancer can be affected by lifestyle choices. 
  
 Factors that can make your risk of colorectal cancer higher include:    Close relatives 
(parents, brothers, sisters, or children) who have had colorectal cancer  History of colorectal 
polyps  Obesity  Cigarette smoking  Inactive lifestyle    
    
Factors that can lower your risk of colorectal cancer include:    Colorectal cancer screening 
 Regular use of aspirin and NSAID’s  Maintaining a healthy weight Regular, vigorous 
exercise (all activities that cause sweating and heavy breathing)  A diet high in vegetables 
 Hormone replacement therapy use in women  
 
 
 
Q88   
 
Not at all 
carefully (1) 
Slightly 
carefully (2) 
Somewhat 
carefully (3) 
Moderately 
carefully (4) 
Very 
carefully (5) 
To what 
extent did 
you carefully 
review the 
information 
on this page? 
(1)  
o  o  o  o  o  
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Q89 Timing 
First Click  (1) 
Last Click  (2) 
Page Submit  (3) 
Click Count  (4) 
 
End of Block: WOMEN - CON MSG 
 
Start of Block: POST-RP Group 1 
 
 
Q90  
YOU AND COLON CANCER   
    
  On a scale from 0 to 100 %, how would you rate the probability that you will develop colorectal 
cancer in the future?  
________________________________________________________________ 
 
 
  
 
Q91       
 
Very unlikely 
(1) 
Unlikely (2) 
Neither likely 
nor unlikely 
(3) 
Likely (4) 
Very likely 
(5) 
How likely is 
it that you 
will get 
colorectal 
cancer at 
some point in 
the future? 
(Q91)  
o  o  o  o  o  
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Q92       
 
Much lower 
(1) 
A little lower 
(2) 
The same (3) 
A little higher 
(4) 
Much higher 
(5) 
How do you 
think your 
chance of 
developing 
colorectal 
cancer in the 
future 
compares to 
the average 
person of 
your gender 
and age? 
(Q92)  
o  o  o  o  o  
 
 
 
  
 
Q93       
 Very low (1) Low (2) 
Neither low 
nor high (3) 
High (4) Very high (5) 
The way I 
look after my 
heath means 
that my odds 
of getting 
colorectal 
cancer in the 
future are: 
(Q93)  
o  o  o  o  o  
 
 
End of Block: POST-RP Group 1 
 
Start of Block: POST-RP Group 2 
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Q94     
 Not at all (1) A little (2) 
A moderate 
amount (3) 
A lot (4) Extremely (5) 
How worried 
are you about 
developing 
colorectal 
cancer in the 
future? 
(Q94_1)  
o  o  o  o  o  
How fearful 
are you about 
developing 
colorectal 
cancer in the 
future? 
(Q94_2)  
o  o  o  o  o  
How nervous 
are you about 
developing 
colorectal 
cancer in 
your lifetime? 
(Q94_3)  
o  o  o  o  o  
How 
concerned 
are you about 
developing 
colorectal 
cancer in 
your lifetime? 
(Q94_4)  
o  o  o  o  o  
How easy is 
it for you to 
imagine 
yourself 
developing 
colorectal 
cancer in the 
future? 
(Q94_5)  
o  o  o  o  o  
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When you 
think about 
colorectal 
cancer for a 
moment, to 
what extent 
do you feel 
fearful? 
(Q94_6)  
o  o  o  o  o  
When you 
think about 
colorectal 
cancer for a 
moment, to 
what extent 
do you feel 
worried? 
(Q94_7)  
o  o  o  o  o  
When you 
think about 
colorectal 
cancer for a 
moment, to 
what extent 
do you feel 
anxious? 
(Q94_8)  
o  o  o  o  o  
 
 
End of Block: POST-RP Group 2 
 
Start of Block: POST-RP Group 3 
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Q95     
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
When I think 
carefully 
about my 
lifestyle it 
does seem 
possible that I 
could get 
colorectal 
cancer. 
(Q95_1)  
o  o  o  o  o  
If I look at 
myself as if I 
was a doctor, 
I realize that 
my behavior 
puts me at 
risk of getting 
cancer. 
(Q95_2)  
o  o  o  o  o  
I feel very 
vulnerable to 
colorectal 
cancer. 
(Q95_3)  
o  o  o  o  o  
I am 
confident that 
I will not get 
colorectal 
cancer. 
(Q95_4)  
o  o  o  o  o  
I would be 
lying if I said 
“There is no 
chance of me 
getting 
colorectal 
cancer.” 
o  o  o  o  o  
  
 
 
 
 177 
(Q95_5)  
My first 
reaction when 
I hear of 
someone 
getting 
colorectal 
cancer is 
“that could be 
me 
someday.” 
(Q95_6)  
o  o  o  o  o  
 
 
End of Block: POST-RP Group 3 
 
Start of Block: POST-BCA RP 
 
 
Q96  
YOU AND BREAST CANCER   
    
  On a scale from 0 to 100 %, how would you rate the probability that you will develop BREAST 
cancer in the future?  
________________________________________________________________ 
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Q97       
 
Very unlikely 
(1) 
Unlikely (2) 
Neither likely 
nor unlikely 
(3) 
Likely (4) 
Very likely 
(5) 
How likely is 
it that you 
will get 
BREAST 
cancer at 
some point in 
the future? 
(Q97)  
o  o  o  o  o  
 
 
 
  
 
Q98       
 
Much lower 
(1) 
A little lower 
(2) 
The same (3) 
A little higher 
(4) 
Much higher 
(5) 
How do you 
think your 
chance of 
developing 
BREAST 
cancer in the 
future 
compares to 
the average 
person of 
your gender 
and age? 
(Q98)  
o  o  o  o  o  
 
 
End of Block: POST-BCA RP 
 
Start of Block: POST-DEM RP 
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Q99  
YOU AND DEMENTIA   
    
  On a scale from 0 to 100 %, how would you rate the probability that you will develop 
DEMENTIA in the future?  
________________________________________________________________ 
 
 
  
 
Q100       
 
Very unlikely 
(1) 
Unlikely (2) 
Neither likely 
nor unlikely 
(3) 
Likely (4) 
Very likely 
(5) 
How likely is 
it that you 
will get 
DEMENTIA 
at some point 
in the future? 
(Q100)  
o  o  o  o  o  
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Q101       
 
Much lower 
(1) 
A little lower 
(2) 
The same (3) 
A little higher 
(4) 
Much higher 
(5) 
How do you 
think your 
chance of 
developing 
DEMENTIA 
in the future 
compares to 
the average 
person of 
your gender 
and age? 
(Q101)  
o  o  o  o  o  
 
 
End of Block: POST-DEM RP 
 
Start of Block: POST-BI 
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Q102  
HEALTH BEHAVIORS 
 Not at all (1) A little (2) 
A moderate 
amount (3) 
A lot (4) Extremely (5) 
CRCS UTD != 1 
How likely 
are you to get 
tested for 
colorectal 
cancer in the 
next 6 
months? 
(Q102_1)  
o  o  o  o  o  
CRCS UTD = 1 
How likely 
are you to get 
tested for 
colorectal 
cancer (when 
you are due 
to be tested 
again)? 
(Q102_2)  
o  o  o  o  o  
Are you male or 
female? = 
Female 
And Mammo 
UTD != 1 
How likely 
are you to get 
a 
mammogram 
in the next 6 
months? 
(Q102_3)  
o  o  o  o  o  
Are you male or 
female? = 
Female 
And Mammo 
o  o  o  o  o  
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UTD = 1 
How likely 
are you to get 
a 
mammogram 
(when you 
are due to get 
a 
mammogram 
again? 
(Q102_4)  
How likely 
are you to 
improve your 
diet in the 
next 6 
months? 
(Q102_5)  
o  o  o  o  o  
How likely 
are you to 
increase your 
physical 
activity in the 
next 6 
months? 
(Q102_6)  
o  o  o  o  o  
How likely 
are you to 
talk to a 
doctor about 
getting tested 
for colorectal 
cancer in the 
next 6 
months? 
(Q102_7)  
o  o  o  o  o  
 
 
 
Page Break  
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Q103 Do you have a healthy diet? 
o YES, I have a healthy diet and I have for MORE than 6 months. (1)  
o YES, I have a healthy diet and I have for LESS than 6 months. (2)  
o NO, but I intend to improve my diet in the next 30 days. (3)  
o NO, but I intend to improve my diet in the next 6 months. (4)  
o NO, and I do NOT intend to improve my diet in the next 6 months. (5)  
 
 
  
 
Q104 Are you physically active? 
o YES, I am physically active and I have been for MORE than 6 months. (1)  
o YES, I am physically active and I have been for LESS than 6 months. (2)  
o NO, but I intend to increase my physical activity in the next 30 days. (3)  
o NO, but I intend to increase my physical activity in the next 6 months. (4)  
o NO, and I do NOT intend to increase my physical activity in the next 6 months. (5)  
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Q105 Do you screen for colorectal cancer regularly (as recommended by your healthcare 
provider)? 
o YES, I screen for colorectal cancer regularly, AND I intend to get screened for colorectal 
cancer when I am due again. (1)  
o YES, I screen for colorectal cancer regularly, BUT I do NOT intend to get screened for 
colorectal cancer when I am due again. (2)  
o NO, but I intend to get screened for colorectal cancer in the next 30 days. (3)  
o NO, but I intend to get screened for colorectal cancer in the next 6 months. (4)  
o NO, and I do NOT intend to get screened for colorectal cancer in the next 6 months. (5)  
 
 
Display This Question: 
If Are you male or female? = Female 
  
 
Q106 Do you screen for breast cancer regularly (as recommended by your healthcare provider)? 
o YES, I screen for breast cancer regularly, AND I intend to get screened for breast cancer 
when I am due again. (1)  
o YES, I screen for breast cancer regularly, BUT I do NOT intend to get screened for breast 
cancer when I am due again. (2)  
o NO, but I intend to get screened for breast cancer in the next 30 days. (3)  
o NO, but I intend to get screened for breast cancer in the next 6 months. (4)  
o NO, and I do NOT intend to get screened for breast cancer in the next 6 months. (5)  
 
End of Block: POST-BI 
 
Start of Block: POST-Beliefs/AVOID 
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Q107 ATTITUDES AND BELIEFS        How much do you agree or disagree with each of the 
following statements? 
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
Cancer is most 
often caused by a 
person's behavior 
or lifestyle. 
(Q107_1)  
o  o  o  o  o  
It seems like 
everything 
causes cancer. 
(Q107_2)  
o  o  o  o  o  
There's not much 
you can do to 
lower your 
chances of 
getting cancer. 
(Q107_3)  
o  o  o  o  o  
There are so 
many different 
recommendations 
about preventing 
cancer, it's hard 
to know which 
ones to follow. 
(Q107_4)  
o  o  o  o  o  
I'd rather not 
know my chance 
of getting cancer. 
(Q107_5)  
o  o  o  o  o  
 
 
End of Block: POST-Beliefs/AVOID 
 
Start of Block: Knowledge 
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Q108 Please indicate whether each of the following either increases, decreases, or does not 
affect risk for colorectal cancer: 
 Increases Risk (1) Decreases Risk (2) 
Do Not Affect Risk 
(3) 
Being older than 49 
years old (>= 50) 
(Q108_1)  
o  o  o  
Getting screened for 
colorectal cancer 
(Q108_2)  
o  o  o  
Having a family 
history of colorectal 
cancer (Q108_3)  
o  o  o  
Having a colorectal 
polyp (Q108_4)  o  o  o  
Stress (Q108_5)  o  o  o  
Obesity (Q108_6)  o  o  o  
Eating more than 3 
servings of red meat a 
week (Q108_7)  
o  o  o  
Engaging in at least 
30 minutes of 
physical activity a day 
(Q108_8)  
o  o  o  
Please select 
decreases risk for this 
statement (Q108_attn)  
o  o  o  
Taking aspirin daily 
(Q108_9)  o  o  o  
Eating less than 5 
servings of fruits and 
vegetables a day 
(Q108_10)  
o  o  o  
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Smoking (Q108_11)  o  o  o  
Drinking more than 
one serving of alcohol 
each day (Q108_12)  
o  o  o  
 
 
End of Block: Knowledge 
 
Start of Block: Saliency 
  
 
Q109 How much do you think health behaviors such as diet, exercise, and screening tests 
determine whether or not a person will develop colorectal cancer? 
 Not at all (1) A little (2) 
A moderate 
amount (3) 
A lot (4) 
Completely 
(5) 
  (Q109)  o  o  o  o  o  
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Q110  
Improving my diet would be:  
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
Important 
(Q110_1)  o  o  o  o  o  
Worthless 
(Q110_2)  o  o  o  o  o  
Wise 
(Q110_3)  o  o  o  o  o  
Beneficial 
(Q110_4)  o  o  o  o  o  
Bad/Negative 
(Q110_5)  o  o  o  o  o  
 
 
 
   
 
Q111 Increasing my physical activity would be:  
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
Important 
(Q111_1)  o  o  o  o  o  
Worthless 
(Q111_2)  o  o  o  o  o  
Wise 
(Q111_3)  o  o  o  o  o  
Beneficial 
(Q111_4)  o  o  o  o  o  
Bad/Negative 
(Q111_5)  o  o  o  o  o  
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Q112 Being tested for colorectal cancer would be:  
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
Important 
(Q112_1)  o  o  o  o  o  
Worthless 
(Q112_2)  o  o  o  o  o  
Wise 
(Q112_3)  o  o  o  o  o  
Beneficial 
(Q112_4)  o  o  o  o  o  
Bad/Negative 
(Q112_5)  o  o  o  o  o  
 
 
End of Block: Saliency 
 
Start of Block: PERC CONSEQ And PERC Control 
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Q113 Indicate your level of agreement with the following statements:  
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
Improving 
my diet 
would lower 
my risk of 
getting 
colorectal 
cancer. 
(Q113_1)  
o  o  o  o  o  
Exercising 
more would 
lower my 
risk of 
getting 
colorectal 
cancer. 
(Q113_2)  
o  o  o  o  o  
Being tested 
for colorectal 
cancer would 
lower my 
risk of 
getting it. 
(Q113_3)  
o  o  o  o  o  
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Q114     
 
Strongly 
disagree (1) 
Disagree (2) 
Neither agree 
nor disagree 
(3) 
Agree (4) 
Strongly 
agree (5) 
There are 
things I can 
do to control 
whether I get 
colorectal 
cancer or not. 
(Q114_1)  
o  o  o  o  o  
What I do 
can 
determine 
whether I get 
colorectal 
cancer or not. 
(Q114_2)  
o  o  o  o  o  
My actions 
will have no 
effect on 
whether I get 
colorectal 
cancer or not. 
(Q114_3)  
o  o  o  o  o  
Nothing I do 
will affect 
my colorectal 
cancer risk. 
(Q114_4)  
o  o  o  o  o  
 
 
End of Block: PERC CONSEQ And PERC Control 
 
Start of Block: Demographics 
  
 
Q115  
PLEASE TELL US  ABOUT YOURSELF   
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  What language do you usually speak at home? 
o English  (1)  
o Spanish  (2)  
o Other  (3)  
 
 
  
 
Q116 What is the highest level of education you completed? 
▼ Less than high school or some high school (1) ... Master's degree or higher (6) 
 
 
  
 
Q117 What is your employment status? 
▼ Employed full-time (1) ... Disability (6) 
 
 
  
 
Q118 What is your marital status? 
▼ Never married (1) ... Widowed (4) 
 
 
  
 
Q119 In general, how would you describe your health? 
▼ Excellent (1) ... Poor (5) 
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Q120 How confident are you filling out medical forms by yourself? 
▼ Extremely (1) ... Not at all (5) 
 
 
  
 
Q121 Do you have any kind of health care coverage, including health insurance obtained through 
employment or purchased directly, as well as government programs like Medicare and 
Medicaid? 
o Yes  (1)  
o No  (0)  
 
 
 
 
Q122 Do you have one person you think of as your personal doctor or healthcare provider? 
o Yes  (1)  
o No  (0)  
 
 
Display This Question: 
If Do you have one person you think of as your personal doctor or healthcare provider? = Yes 
  
 
Q123 What type of health care provider is this person? 
▼ Primary or general care physician (1) ... Other (4) 
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Display This Question: 
If Are you male or female? = Female 
  
 
Q124 Have you ever been told by a doctor or other healthcare provider that you have breast 
cancer, ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS)? 
o Yes  (1)  
o No  (0)  
 
 
Display This Question: 
If Are you male or female? = Female 
  
 
Q125 Have you ever been told by a doctor or other healthcare provider that you have any 
OTHER type of cancer? 
o Yes  (1)  
o No  (0)  
 
 
Display This Question: 
If Are you male or female? = Male 
  
 
Q126 Have you ever been told by a doctor or other healthcare provider that you have any type of 
cancer? 
o Yes  (1)  
o No  (0)  
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Display This Question: 
If Have you ever been told by a doctor or other healthcare provider that you have any type of cancer? = Yes 
Or Have you ever been told by a doctor or other healthcare provider that you have any OTHER type of... = Yes 
 
Q127 What type of cancer were you told you have? 
________________________________________________________________ 
 
 
  
 
Q128 In which state do you currently reside? 
▼ Alabama (1) ... I do not reside in the United States (99) 
 
End of Block: Demographics 
 
Start of Block: Quality/COM HYP/Next Steps 
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Q129  
FINAL QUESTION SET 
 
 
 
   
 The information you received about your estimated risk (%) of getting colon cancer was…? 
 1 (1) 2 (2) 3 (3) 4 (4) 5 (5)  
Not 
Relevant o  o  o  o  o  Relevant 
Not Useful o  o  o  o  o  Useful 
Not 
Informative o  o  o  o  o  Informative 
Not 
Credible o  o  o  o  o  Credible 
Not 
Accurate o  o  o  o  o  Accurate 
Too much 
information o  o  o  o  o  
Right 
amount of 
information 
Hard to 
Understand o  o  o  o  o  
Easy to 
Understand 
Too little 
information o  o  o  o  o  
Right 
amount of 
information 
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Q130  
The information you received about what can lower your risk of colon cancer was…? 
 1 (1) 2 (2) 3 (3) 4 (4) 5 (5)  
Not 
Relevant o  o  o  o  o  Relevant 
Not Useful o  o  o  o  o  Useful 
Not 
Informative o  o  o  o  o  Informative 
Not 
Credible o  o  o  o  o  Credible 
Not 
Accurate o  o  o  o  o  Accurate 
Too much 
information o  o  o  o  o  
Right 
amount of 
information 
Hard to 
Understand o  o  o  o  o  
Easy to 
Understand 
Too little 
information o  o  o  o  o  
Right 
amount of 
information 
 
 
 
Page Break  
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Q131 Based on the colorectal cancer risk information you received, please indicate your level 
of interest in the following activities: 
 
Not 
interested at 
all (1) 
Slightly 
interested (2) 
Moderately 
interested (3) 
Very 
interested (4) 
Extremely 
interested (5) 
Getting 
assistance with 
goal setting to 
address 
identified 
health risks 
(Q131_1)  
o  o  o  o  o  
Discussing 
your health 
risk with 
doctor or 
healthcare 
provider 
(Q131_2)  
o  o  o  o  o  
Learning 
about 
colorectal 
cancer 
screening 
programs in 
your 
community 
(Q131_3)  
o  o  o  o  o  
Learning 
about fitness 
programs (i.e., 
walking 
groups) in 
your 
community 
(Q131_4)  
o  o  o  o  o  
Receiving 
health risk 
information 
related to other 
conditions 
o  o  o  o  o  
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(i.e., 
cardiovascular 
disease) 
(Q131_5)  
Participating 
in clinical 
trials to reduce 
your risk 
(Q131_6)  
o  o  o  o  o  
Learning 
about nutrition 
assistance (i.e., 
diet guidance) 
in your 
community 
(Q131_7)  
o  o  o  o  o  
Are you male or 
female? = Female 
Learning 
about 
mammography 
screening 
programs in 
your 
community 
(Q131_8)  
o  o  o  o  o  
Participating 
in health 
programs in 
your 
workplace 
(Q131_9)  
o  o  o  o  o  
 
 
End of Block: Quality/COM HYP/Next Steps 
 
Start of Block: Goodbye 
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The colorectal cancer risk estimate provided to you in this survey was the average lifetime risk 
for someone your gender living in the United States. If you are interested in learning more about 
your personal risk, please visit the following website: 
https://www.cancer.gov/colorectalcancerrisk/Default.aspx   
    
For more information about colon cancer:   
American Cancer Society: https://www.cancer.org/cancer/colon-rectal-cancer.html   
Centers for Disease Control and Prevention: https://www.cdc.gov/cancer/colorectal/   
Mayo Clinic: http://www.mayoclinic.org/diseases-conditions/colon-cancer/home/ovc-20188216   
National Cancer Institute: https://www.cancer.gov/types/colorectal  
 
End of Block: Goodbye 
 
 
 
 
